1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 1997 Commission file number 0-25062
ENVOY CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Tennessee 62-1575729
- -------------------------------------- -------------------------
(State or Other Jurisdiction (I.R.S. Employer
of Incorporation or Organization) Identification No.)
15 Century Boulevard, Suite 600
Nashville, Tennessee 37214
- --------------------------------------- -------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code: (615) 885-3700
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, No Par Value
----------------------------------------------------------
(Title of Class)
Indicate by check mark whether the Registrant: (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No
----- ------
Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of Registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [X]
The aggregate market value of the voting stock held by non-affiliates
of the Registrant as of February 27, 1998, was approximately $803,720,000. The
market value calculation was determined using the closing sale price of the
Registrant's common stock on February 27, 1998, as reported on The Nasdaq Stock
Market.
The number of shares outstanding of the Registrant's common stock as of
February 27, 1998 was 21,009,962.
DOCUMENTS INCORPORATED BY REFERENCE
Documents from which Portions are
Part of Form 10-K Incorporated by Reference
- ----------------- ---------------------------------
Part III Portions of the Proxy Statement relating to the
Annual Meeting of Shareholders to be held on June
4, 1998 are incorporated by reference into Items
10, 11, 12 and 13.
[The Exhibit Index is located
on page ___ of ___ total pages.]
2
ENVOY CORPORATION
TABLE OF CONTENTS
FORM 10-K ANNUAL REPORT
PART I
ITEM 1. Business .................................................................. 1
ITEM 2. Properties ................................................................ 10
ITEM 3. Legal Proceedings ......................................................... 10
ITEM 4. Submission of Matters to a Vote of Security Holders ....................... 10
PART II
ITEM 5. Market for the Registrant's Common Equity and Related Shareholder Matters . 11
ITEM 6. Selected Financial Data ................................................... 12
ITEM 7. Management's Discussion and Analysis of Financial Condition and
Results of Operations .................................................... 13
ITEM 8. Financial Statements and Supplementary Data ............................... 24
ITEM 9. Changes in and Disagreements With Accountants on Accounting
and Financial Disclosure .................................................. 24
PART III
ITEM 10. Directors and Executive Officers of the Registrant ........................ 25
ITEM 11. Executive Compensation .................................................... 25
ITEM 12. Security Ownership of Certain Beneficial Owners and Management............. 25
ITEM 13. Certain Relationships and Related Transactions ............................ 25
PART IV
ITEM 14. Exhibits, Financial Statement Schedules, and Reports on Form 8-K .......... 26
SIGNATURES .............................................................................. 30
3
ENVOY CORPORATION
PART I
ITEM 1. BUSINESS
GENERAL
ENVOY Corporation, a Tennessee corporation ("ENVOY" or the "Company"), is
a provider of electronic data interchange ("EDI") services to participants in
the health care market, including pharmacies, physicians, hospitals, dentists,
billing services, commercial insurance companies, managed care organizations,
state and federal governmental agencies and others. The Company provides health
care EDI services on a real-time and batch-processing basis by utilizing
proprietary computer and telecommunications software and microprocessor
technology. ENVOY is one of the largest processors of electronic real-time
pharmacy and commercial third-party payor batch transactions in the United
States based upon annual transaction volume. ENVOY's transaction network
consists of approximately 206,000 physicians, 34,000 pharmacies, 38,000
dentists, 4,400 hospitals and 784 payors, including approximately 46 Blue Cross
Blue Shield Plans, 50 Medicare Plans and 38 Medicaid Plans.
The Company was incorporated in Tennessee in August 1994 as a wholly-owned
subsidiary of ENVOY Corporation, a Delaware corporation which was formed in 1981
(the "Predecessor"). The Predecessor was formed to develop and market electronic
transaction processing services for the financial services and health care
markets. In June 1995, in order to facilitate the transfer of the financial
services business to First Data Corporation ("First Data"), the assets and
liabilities of the Predecessor associated with the health care business were
transferred to the Company. The Company was spun-off to shareholders through a
stock dividend distribution (the "Distribution") and the Predecessor was merged
into First Data.
As part of its strategy to maintain and enhance its leadership position in
the health care transaction processing industry, the Company has completed
several acquisitions, the most significant of which are the acquisition of
National Electronic Information Corporation ("NEIC") in March 1996 and the
acquisition of Healthcare Data Interchange Corporation ("HDIC") in August 1997.
See "Recent Acquisitions." In addition, on February 27, 1998, the Company
completed business combinations with the three companies operating the
ExpressBill(R) patient statement processing and printing services businesses for
an aggregate of 3,500,000 shares of ENVOY Common Stock. Shareholders of XpiData,
Inc. ("XpiData"), based in Scottsdale, Arizona, received 1,365,000 shares and
shareholders of Professional Office Services, Inc. ("POS") and its affiliated
company, Automated Revenue Management, Inc. ("ARM", and together with XpiData
and POS, sometimes collectively referred to herein as the "ExpressBill
Companies"), both of which are based in Toledo, Ohio, received an aggregate of
2,135,000 shares. The ExpressBill Companies' patient statement services include
electronic data transmission and formatting, statement printing and mailing
services for health care providers and practice management system vendors. It is
anticipated that the business combinations with the ExpressBill Companies will
be accounted for as poolings of interests.
INDUSTRY BACKGROUND
Throughout the 1980's, advances in computer software, telecommunications
and microprocessor technology enabled the development of on-line, real-time
systems that electronically capture and transmit information, replacing the
recording and processing of transaction information on paper. In addition to
offering greater convenience, these electronic systems reduce processing costs,
settlement delays and losses from fraudulent transactions. The earliest and most
significant advances in electronic transaction processing
4
occurred in the financial services market, particularly in the areas of credit
card authorization and settlement. The Company believes the evolution of
electronic transaction processing in the financial services market has created
the framework for automation of other markets, such as health care, still
dominated by paper-based processing.
The first major departure from paper-based claims processing in the health
care market occurred in the late 1980's in the pharmacy industry. Medicare and
Medicaid payment reforms and cost saving initiatives by third-party commercial
payors and large retail pharmacy chains led to a significant increase in
electronic processing of pharmacy third-party claims. The development and use by
pharmacies of practice management software products that include the capability
of connecting with an electronic claims processing network also facilitated the
movement to electronic claims processing.
The Company believes EDI transaction processing offers a number of
benefits to health care payors and providers. The elimination or reduction of
paper-based transactions significantly lowers claims processing costs of payors,
and on-line encounter and referral information provides more efficient medical
cost management for managed care organizations and networked providers. In
addition, payors are able to more easily detect fraud and screen for unusual
utilization trends. From the health care providers' standpoint, information
pertaining to eligibility, authorization and reimbursement can be more easily
accessed and transmitted. By processing claims electronically, providers also
reduce overhead costs and staff time and improve accounts receivable management.
There are many types of transactions, information exchanges and other
communications that occur between the various participants in the health care
industry, including patients, pharmacies, physicians, hospitals, dentists,
billing services, commercial insurance companies, managed care organizations,
state and federal government agencies and others. While electronic transaction
processing for certain portions of the health care market has increased over the
past few years, the majority of health care transactions continue to be
paper-based and manually-processed. Existing EDI services in this market
primarily consist of: (i) on-line verification of patient eligibility by
pharmacies, health care providers and third-party payors (both commercial and
governmental) through direct network communications; (ii) verification that the
provider is eligible to treat the patient; (iii) verification that the patient
is eligible for the treatment; (iv) filing of encounter data; (v) referral
management for providers and payors; and (vi) batch processing of health care
reimbursement claims through a central clearinghouse.
Health care providers initiate electronic transaction processing through
dedicated point-of-service terminals, stand alone software or software
integrated with the provider's management information system. Providers can
verify patient eligibility or obtain authorization for services at the time of
appointment or registration by transmitting patient data to the processor across
a telecommunication line. The processor then interfaces with the payor to obtain
an eligibility or authorization confirmation which is transmitted back to the
provider. The submission of claims generally occurs by providers aggregating
claims throughout the day and submitting them electronically to a clearinghouse
in batch. Claims are sorted, formatted and edited by the clearinghouse, and are
then forwarded electronically to the payor. The claim is processed by the payor
and the adjudicated response is communicated back to the provider. To the extent
required, the payor sends a check to the provider or, in certain circumstances,
initiates an electronic funds transfer to the provider's account.
According to the Health Data Directory, approximately 83% of the 1.4
billion and 86% of the 1.7 billion third-party pharmacy claims processed in 1996
and 1997, respectively, were processed
2
5
electronically. The Company believes that only a small percentage of nonclaim
pharmacy transactions, such as the delivery of prescriptions by the physician to
the pharmacist or formulary inquiries to pharmacy benefit managers, are
delivered electronically through real-time on-line systems. The Company believes
that there are opportunities to expand electronic processing to other areas in
the pharmacy market. Also, as the population continues to grow and more benefit
plans include prescription programs, the Company believes the demand for
real-time processing of pharmacy transactions should continue to increase.
In addition to pharmacies, other providers, including hospitals,
physicians and dentists, transmit third-party reimbursement claims
electronically, largely on a batch basis through claims clearinghouses.
According to the Health Data Directory, approximately 42% of the 2.5 billion
non-pharmacy health care claims processed in 1997 were processed electronically.
The recent growth of managed care and governmental health care cost containment
efforts have increased the use of real time transaction processing by hospitals
and physicians by emphasizing not only lower costs, but improved operating
efficiencies and increasing accountability. Certain state Medicaid programs
permit providers to electronically verify Medicaid eligibility on a real-time
basis, and certain managed care companies have encouraged their provider
networks to utilize real-time EDI for authorizations, encounter reports and
referrals. The Company believes that there are significant opportunities for
further expansion of EDI transactions to the non-pharmacy sector of the health
care market, both for claims processing as well as for clinical and other
purposes.
COMPANY SERVICES
ENVOY provides various EDI services to participants in the health care
market through a real-time and batch clearinghouse network. Through its
transaction network, ENVOY provides an electronic link, directly and indirectly
through other clearinghouses or vendors, to approximately 206,000 physicians,
34,000 pharmacies, 38,000 dentists, 4,400 hospitals and 784 payors, including
approximately 46 Blue Cross Blue Shield Plans, 50 Medicare Plans and 38 Medicaid
Plans.
Real-time Transaction Processing. The Company provides real-time
transaction processing for pharmacy claim adjudication and managed care
transactions for health care providers and payors.
A standard pharmacy transaction is the inquiry by the pharmacy, through a
point-of-service terminal or personal computer terminal, to determine whether
the patient is covered by a benefit program. After eligibility is confirmed, the
claim is settled and the payor transmits to the pharmacy the amount and timing
of the pending payment. As of December 31, 1997, ENVOY's EDI network was linked
to approximately 34,000 of the estimated 51,000 retail pharmacies in the United
States, including 40 of the top 50 retail pharmacy chains.
ENVOY's real-time managed care transactions between providers and payors
include (i) verification of the patient's enrollment in a program; (ii)
verification that the provider is eligible to treat the patient; (iii)
verification that the patient is eligible for a particular treatment; (iv)
filing of encounter data; (v) referral to a specialist; and (vi) other ancillary
transactions. These transactions are enabled by the Company's network
connections to various databases.
The Company has access to managed care and commercial insurer databases
for Prudential, CIGNA, Aetna U.S. Healthcare, Oxford Health Plans, MetraHealth,
Pacificare, Blue Cross of California, Empire Blue Cross and Blue Shield, Blue
Cross and Blue Shield for the National Capital Area, Blue Cross and Blue Shield
of Arkansas, QualMed, Access Med Plus and Health 123, and is a sponsored
participant to the Blue
3
6
Cross and Blue Shield BluesNet network. For Medicaid eligibility verification
and related transactions, the Company has access to state databases in Alabama,
Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois,
Indiana, Iowa, Kansas, Kentucky, Mississippi, Missouri, New Jersey, New Mexico,
New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Dakota, Tennessee,
Texas, Washington and Wyoming. In addition, if the patient wishes to pay the
deductible or co-payment amounts by credit card, ENVOY's services provide the
ability to obtain payment authorization and verification at the provider's
offices.
Batch Transaction Processing. With the acquisition of NEIC, ENVOY became
one of the nation's largest processors of commercial third-party payor claims
and enhanced its electronic network with connections to a significant number of
health care providers and payors across the United States. Batch transactions
are predominantly used to process reimbursement claims in traditional
fee-for-service commercial or government payor systems and to process encounter
data in capitated environments. These transactions are neither time-sensitive
nor easily processed on a real-time basis and, as a result are processed on a
collective and delayed basis. To submit claims, health care providers collect
data throughout the day and then electronically forward these claims in bulk to
a clearinghouse. ENVOY's clearinghouse electronically collects and verifies
receipt of the claims and performs reformatting required to conform to a
particular payor's specifications and editing, aggregates daily transactions by
payor and transmits claims to payors based upon each payor's chosen
communications protocols. ENVOY's transaction network is connected with 650 of
the commercial third-party payors, including all of the top 20 commercial payors
(based upon the number of members covered by such third-party payors).
EDI Products and Interfaces. The Company has developed a range of hardware
and software products and interfaces to facilitate the adoption of EDI by its
customers. In addition, ENVOY supports industry standards of the American
National Standards Institute, X12N Subcommittee and Healthcare Financing
Administration National Standards.
ENline(R). The Company's ENline family of proprietary software
products performs all of the transactions of a stand alone point-of-service
terminal and has enhanced functionality to facilitate both batch and
real-time processing. The point-of-service terminal product, called ENline
Genesis, is designed to handle real-time transactions and allow the Company
to rapidly and cost effectively connect a significant number of providers
into the transaction network. The point-of-service terminals can be
accessed remotely to modify application software and communications
parameters, allowing the Company the flexibility to implement changes in
services relatively easily. Point-of-service terminals often are purchased
from the Company by payors, who are sponsoring a managed care network, and
offered by the payors to providers free of charge. In addition, providers
may purchase terminals from the Company for a fee.
The Company also has developed certain ENline PC-based products with
enhanced functionality features and open Application Program Interfaces
("APIs"). The APIs are established at the operating system level and are
designed to enable the Company's software to run on a wide variety of
operating systems including DOS, UNIX and Windows. The ENline PC-based
products can either function as a stand alone data entry system or work in
conjunction with physician practice management software. The stand alone
version, ENline Companion, is offered directly to providers. ENline Synergy
is designed for integration into a practice management software product.
The Company, in conjunction with the practice management vendor, integrates
ENline Synergy into the practice management system for distribution by the
practice management vendor to the provider. ENline Synergy also controls
the
4
7
editing and distribution of the information from the practice management
system to the Company's network.
Automatic Eligibility Verification. During 1996, the Company acquired
technology for the automation of eligibility requests through the
acquisition of National Verification Systems, L.P. ("NVS"). This technology
interfaces with hospital and large practice management information systems
to automatically verify patient eligibility at the time of admission or
scheduling. Eligibility requests are obtained from the Company's real-time
medical switch. In addition to eligibility verification, the Company's
eligibility verification system provides statistical reporting on patient
demographics for hospitals and/or physician practices.
Automatic Transaction Posting. Through the acquisition of Diverse
Software Solutions, Inc. ("DSS") in March 1997, the Company acquired EDI
technology used for automatic posting of transactions into a hospital or
practice management information system. See "Recent Acquisitions-Diverse
Software Solutions, Inc." This technology, which has been integrated to
work in tandem with NVS's automatic eligibility verification technology,
uses transactions obtained from the Company's real-time and batch
processing centers to perform automated remittance posting, accelerated
secondary billing and member update of eligibility information.
Patient Statements. Through the combinations with the ExpressBill
Companies, the Company is able to offer automated patient billing services to
the health care provider and hospital markets. These services include electronic
data transmission and formatting, statement printing and mailing services for
health care providers and practice management system vendors. See "Recent
Acquisitions-ExpressBill Companies."
Customer Service. As an adjunct to its transaction processing services, the
Company maintains customer service facilities with help desks for real-time and
batch transaction customer inquiries. Client support employs a modern call
tracking and response system which is directly connected to the real-time and
batch processing centers. The customer service staff is available via a
toll-free telephone number. Customer support services are frequently included in
the contract price for transaction processing services, but also may be billed
separately, depending upon the specific contract terms. The Company also offers
other services, such as on-site and telephone product training, installation and
terminal repair and replacement.
SALES AND MARKETING
The Company develops and maintains payor, provider and vendor
relationships primarily through its direct sales and marketing personnel located
throughout the United States. As of February 20, 1998, ENVOY employed
approximately 80 sales and marketing personnel. In addition, the ExpressBill
Companies collectively employ approximately 30 sales and marketing personnel.
The Company's primary sales and marketing strategy focuses on selling its
services to organizations that have relationships with or access to a large
number of providers.
In the pharmacy segment, the Company has traditionally established
relationships with large retail pharmacy chains and pharmacy software vendors.
To market its batch claims processing services, the Company develops
relationships with third-party payors and large submitters of claims. In
addition, the Company works closely with practice management system vendors to
provide an integrated solution to providers. Real-time managed care EDI services
are offered to providers either directly by the Company's sales force or
indirectly through commercial managed care organizations.
5
8
CUSTOMERS
The Company's principal customers consist of health care providers,
such as pharmacies, physicians, hospitals, dentists and billing services, and
third-party payors, such as commercial indemnity insurers, managed care
organizations and state and federal governmental agencies. Primarily as a result
of the HDIC acquisition, the Company has one customer, Aetna U.S. Healthcare,
Inc., that accounted for approximately 15% of the Company's revenues during
1997. See "Recent Acquisitions - Healthcare Data Interchange Corporation." Prior
to 1997, no customer accounted for more than 10% of the Company's revenues.
OPERATIONS
The Company delivers its services through an integrated electronic
transaction processing system, which includes ENVOY-designed software, host
computer hardware, network management, switching services and the ability to
interact with customers' personal computers and a variety of point-of-service
devices, most of which were originally designed by the Company.
ENVOY's real-time host computer system consists of Stratus and Data
General mini computers designed and configured to operate 24 hours a day, seven
days a week. These mini computers are configured to expand to meet increased
transaction volume. The Stratus systems are designed and manufactured to
accommodate a fault-tolerant, nonstop environment. A fault-tolerant environment
is provided for the Data General systems by maintaining on-line standby
computers. The real-time host computer system data center is protected by
automated fire suppression systems designed to extinguish fire with minimal
damage to the computer equipment. The data center is further protected by
uninterruptible power supply systems consisting of diesel generators and battery
backups. In case of loss of commercial power, these systems can supply power to
the data center to continue operations. The data center can only be entered by
accessing a password protected security lock. The software and related data
files are backed up nightly and stored off-site.
The Company's real-time communications network consists of dedicated
circuits, T-l facilities and dial modem ports, which facilitate electronic
real-time communication among payors, providers and other users of
time-sensitive health care information. This communications network is designed
to provide a low cost, multipath host access from a computer modem or point of
service device with minimal delays and a high degree of accuracy and integrity.
The Company manages multiple lease lines to pharmacies and third-party payors.
The Company uses a number of different nationwide public communications networks
to provide access to substantially all potential domestic customers.
To minimize the possibility that a customer might experience delay by a
failed or overloaded circuit, at least two potential communications paths are
provided for each transaction. Utilizing ENVOY's call tracking system,
transactions are rerouted under centralized control to receive the lowest
communications cost available and to bypass failed or overloaded communications
nodes.
A substantial portion of the Company's batch claim processing is
outsourced. Utilizing the Company's proprietary software, a third-party
processes batch transactions on an IBM 3090 mainframe computer coupled with a
RISC-based communications network server. The contractual arrangement between
the Company and the third-party processor requires the processor to maintain 24
hours a day,
6
9
seven days a week processing capability and a "hot site" disaster recovery
system. The Company's current contract with this third-party processor expires
in December 1998.
PROPRIETARY RIGHTS
ENVOY owns certain of the software and systems designs that it uses and
has a limited, perpetual, nonexclusive, royalty-free license to use other
software and systems designs, such as the point-of-service device designs which
were developed by the Predecessor. The Company also licenses certain other
software from third parties.
The Company's success is dependent in part upon electronic transaction
processing technology developed by the Company. A combination of trade secrets,
service mark, copyrights, patents and contract protection is used to establish
and protect that technology. There can be no assurance these legal protections
and the precautions taken by the Company will be adequate to prevent
misappropriation of technology used by ENVOY. In addition, the legal protections
do not prevent independent third-party development of competitive technology.
COMPETITION
The Company faces potential competition in the health care EDI market
not only from other companies that are similarly specialized, but also from
companies involved in other, more highly developed sectors of the electronic
transaction processing market. Such companies could enter into, or focus more
attention on, the health care transaction processing market as it develops. In
addition, the Company faces competition by selected providers bypassing the
Company's electronic network and going directly to the payor. Many of ENVOY's
existing and potential competitors have greater financial, marketing and
technological resources. There can be no assurance that the Company can continue
to compete successfully with its existing and potential competitors in the
health care EDI market.
Factors influencing competition in the health care market include (i)
compatibility with the provider's software and inclusion in practice management
software products, (ii) in the case of the pharmacy market, relationships with
major retail pharmacy chains, and (iii) relationships with third-party payors
and managed care organizations. The Company believes that the breadth, price and
quality of its services are the most significant factors in developing and
maintaining relationships with pharmaceutical chains, third-party payors and
managed care organizations.
EMPLOYEES
As of February 20, 1998, ENVOY had approximately 583 employees,
including approximately 517 salaried and 66 hourly employees (including
temporary employees). In addition, the ExpressBill Companies collectively employ
approximately 236 employees. None of these employees is represented by a union.
ENVOY believes its relationship with its employees is good.
GOVERNMENT REGULATION
Governmental regulatory policies affect the charges for and the terms
of ENVOY's access to private line and public communications networks. ENVOY also
must obtain certification on the applicable communications network for design
innovations for POS devices and proprietary software. Any delays in obtaining
necessary certifications with respect to future products and services could
delay their
7
10
introduction. In addition, the Federal Communications Commission
requires ENVOY's products and services to comply with certain rules and
regulations governing performance. ENVOY believes its existing products and
services comply with all current rules and regulations. ENVOY can give no
assurance, however, that such rules and regulations regarding access to
communications networks will not change in the future. In addition, legislation
has been proposed which would mandate standards and impose restrictions on the
Company's ability to transmit health care transaction data. See "Management's
Discussion and Analysis of Financial Condition and Results of Operations -- Risk
Factors - Health Care Data Legislation." Changes in such rules, regulations or
policies or the adoption of legislation that make it more costly to communicate
on networks could adversely affect the demand for or the cost of supplying
services in the health care EDI transaction processing business.
RECENT ACQUISITIONS
As part of its strategy to maintain and enhance its leadership position
in the health care transaction processing industry, the Company has completed
several acquisitions. A brief description of the acquisitions completed by the
Company since the beginning of 1997 follows:
Diverse Software Solutions, Inc. In March 1997, the Company completed
the acquisition of certain assets and liabilities of DSS. DSS, located near
Tampa, Florida, provides automated electronic remittance advice posting,
supplemental billing products and other advanced software products and services
to medical practices and hospitals.
Healthcare Data Interchange Corporation. In August 1997, the Company
completed the acquisition of all the issued and outstanding capital stock of
HDIC, the EDI health care services subsidiary of Aetna U.S. Healthcare, Inc.
("AUSHC"). In addition, the Company and AUSHC simultaneously entered into a
long-term services agreement under which AUSHC has agreed to use the Company as
its single source clearinghouse and EDI network for all AUSHC electronic health
care transactions.
ExpressBill(R) Companies. On February 27, 1998, the Company completed
business combinations with the ExpressBill Companies pursuant to three separate
agreements and plans of merger. The aggregate consideration for the transactions
consisted of 3,500,000 shares of ENVOY Common Stock. Shareholders of XpiData
received 1,365,000 shares and shareholders of POS and its affiliated company,
ARM, received an aggregate of 2,135,000 shares. The ExpressBill Companies'
patient statement services include electronic data transmission and formatting,
statement printing and mailing services for health care providers and practice
management system vendors. It is anticipated that these combinations will be
accounted for as poolings of interests.
8
11
EXECUTIVE OFFICERS
The following table sets forth certain information concerning the
executive officers of the Company.
Name Age Position
- -------------------- -------- ----------------------------------------------------
Fred C. Goad, Jr. 57 Chairman of the Board and Co-Chief Executive Officer
Jim D. Kever 45 President and Co-Chief Executive Officer
Kevin M. McNamara 42 Senior Vice President and Chief Financial Officer
Harlan F. Seymour 48 Senior Vice President of Corporate Strategy
and Development
Sheila H. Schweitzer 50 Senior Vice President of Operations
Gregory T. Stevens 33 Vice President, General Counsel and Secretary
Mr. Goad has served as the Company's Chairman and Co-Chief Executive
Officer since August 1995, and served as President and a Director since the
Company's incorporation in August 1994. Mr. Goad served as Chief Executive
Officer and a Director of the Predecessor from September 1985 through June 6,
1995. Mr. Goad also is a Director of Performance Food Group Company, a food
distribution company, and is a Director of Oacis Healthcare Systems, Inc., a
clinical healthcare software and services company.
Mr. Kever has served as the Company's President and Co-Chief Executive
Officer since August 1995, and as a Director from incorporation in August 1994.
Prior to such time, he served as the Company's Executive Vice President,
Secretary and General Counsel. Mr. Kever served as a Director and Secretary,
Treasurer and General Counsel of the Predecessor since 1981 and as Executive
Vice President since 1984. Mr. Kever also is a Director of Transaction Systems
Architects, Inc., a supplier of electronic payment software products and network
integration solutions, and 3D Systems Corporation, a manufacturer of
technologically advanced solid imaging systems and prototype models.
Mr. McNamara has served as the Company's Senior Vice President and Chief
Financial Officer since February 1996, and as a Director since July 1997. Before
joining the Company, he served as President of NaBANCO Merchant Services
Corporation, a wholly owned subsidiary of National Bancard Corporation
("NaBANCO"), from October 1994 to December 1995. Mr. McNamara served as Senior
Executive Vice President and Chief Financial Officer of NaBANCO from January
1992 through September 1994.
Mr. Seymour has served as the Company's Senior Vice President of Corporate
Strategy and Development since August 1997, and as a Director since October
1996. Before joining the Company as a full-time employee in August 1997, Mr.
Seymour was a partner in Jefferson Capital Partners, Ltd., an investment banking
firm, from September 1996 to June 1997. He served as Executive Vice President
and Chief Operating Officer, Business Development, of Trigon Blue Cross Blue
Shield, a leading health care insurance services company ("Trigon") from August
1994 to June 1996. Before joining Trigon, Mr. Seymour was with First Financial
Management Corporation ("FFMC") of Atlanta, Georgia, for 11 years,
9
12
serving in a variety of senior corporate positions, where his last
responsibility was President and Chief Executive Officer of First Health
Services Corporation, a wholly-owned subsidiary of FFMC.
Ms. Schweitzer currently serves as the Company's Senior Vice President
of Operations. Before joining the Company in August 1995, Ms. Schweitzer served
from December 1991 to July 1995 as President and Chief Executive Officer of
Medical Management Resources, Inc., a health care EDI services company which is
a wholly-owned subsidiary of The Associated Group, Inc.
Mr. Stevens currently serves as the Company's Vice President, General
Counsel and Secretary. Before joining the Company in September 1996, Mr. Stevens
was an attorney with the law firm of Bass, Berry & Sims PLC in Nashville,
Tennessee since 1990.
ITEM 2. PROPERTIES
ENVOY leases approximately 42,000 square feet of space in an office
building in Nashville, Tennessee under a lease expiring in August 2001. This
facility serves as the corporate headquarters of ENVOY. ENVOY also leases
approximately 27,500 square feet, which consists of a data center and an
operations and customer support center, in Nashville, Tennessee. Approximately
18,500 square feet under this lease expires in May 2005, and the remaining 9,000
square feet under this lease expires in January 2001. The Company's Nashville
data center handles the telecommunications network and computer systems for
real-time pharmacy and health care transactions. In addition, the Company leases
space in Oklahoma City, Oklahoma, and Phoenix, Arizona for small processing
centers. The ExpressBill Companies operate their businesses in leased facilities
located in Toledo, Ohio and Scottsdale, Arizona. The ExpressBill Companies
Toledo facility's lease terminates in 2013 and consists of approximately 93,000
square feet. The ExpressBill Companies' Scottsdale facility is subleased
pursuant to a lease that terminates in 2006 and consists of approximately 50,000
square feet.
ENVOY leases and occupies other offices and operations facilities at
various locations, but the aggregate rental obligations and physical
characteristics of these other facilities are not material to the Company's
business.
ITEM 3. LEGAL PROCEEDINGS
From time to time, ENVOY may be a party to legal proceedings incidental
to its business but believes that none of these proceedings is material to its
business at the present time.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
No matters were submitted to shareholders during the fourth quarter of
1997.
10
13
PART II
ITEM 5. MARKET FOR THE REGISTRANT'S COMMON EQUITY AND RELATED SHAREHOLDER
MATTERS
The Common Stock of ENVOY ("Common Stock") is traded through the
over-the-counter market and is reported on The Nasdaq Stock Market under the
symbol "ENVY". Prices listed below represent actual high and low sale prices as
reported on The Nasdaq Stock Market.
FISCAL YEAR ENDED DECEMBER 31, 1996
First Quarter. . . . . . . . . . . . . . . . . $24.25 $17.13
Second Quarter . . . . . . . . . . . . . . . . 32.75 23.25
Third Quarter. . . . . . . . . . . . . . . . . 40.50 21.50
Fourth Quarter . . . . . . . . . . . . . . . . 42.25 34.00
FISCAL YEAR ENDED DECEMBER 31, 1997
First Quarter. . . . . . . . . . . . . . . . . 38.25 21.88
Second Quarter . . . . . . . . . . . . . . . . 35.75 20.38
Third Quarter. . . . . . . . . . . . . . . . . 37.25 25.50
Fourth Quarter . . . . . . . . . . . . . . . . 32.75 22.38
- ----------
At February 20, 1998, there were approximately 6,500 holders of Common
Stock, including approximately 235 shareholders of record.
ENVOY has never declared or paid cash dividends on its Common Stock and
does not expect to pay cash dividends in the foreseeable future. Any declaration
and payment of cash dividends on the Common Stock will be determined by the
Board of Directors based on a number of factors, including but not limited to,
earnings, financial condition and requirements, restrictions in financing
agreements (if any) and other factors deemed relevant.
11
14
ITEM 6. SELECTED FINANCIAL DATA
YEAR ENDED DECEMBER 31,
------------------------------------------------------------------
1997(1) 1996(2) 1995(3) 1994(3) 1993(3)
------------------------------------------------------------------
(In thousands, except per share data)
STATEMENTS OF OPERATIONS DATA:
Revenues ...................................... $ 113,693 $ 76,584 $ 26,055 $ 20,950 $ 13,979
Operating Loss ................................ (29,274) (35,699) (91) (221) (1,356)
Loss from Operations Before
Income Taxes and Loss in Investee .......... (29,328) (37,323) (224) (192) (1,349)
Income Tax (Expense) Benefit .................. 5,565 (1,577) 0 73 514
Loss in Investee............................... 0 0 (1,776) 0 0
------------------------------------------------------------------
Loss from Continuing
Operations ................................ $ (23,763) $ (38,900) $ (2,000) $ (119) $ (835)
==================================================================
Loss per Common Share from Continuing
Operations ................................ $ (1.47) $ (2.99) $ (0.18) $ (0.01) $ (0.07)
==================================================================
BALANCE SHEET DATA (AT PERIOD END):
Working Capital of Continuing Operations .. $ 18,202 $ 48,424 $ 11,277 $ 7,523 $ 2,274
Assets of Continuing Operations ........... 126,853 133,814 30,150 20,926 11,763
Total Assets .............................. 126,853 133,814 30,150 56,995 49,701
Long-Term Debt and Deferred Taxes ......... 9,277 10,377 10,300 737 508
Shareholders' Equity of Continuing
Operations ............................ 96,069 108,445 15,335 17,156 8,299
Notes: (1) The 1997 results include expenses of $38.0 million for the
write-off of acquired in-process technology associated with the
DSS and HDIC acquisitions. (See Note 4 of Notes to the
Consolidated Financial Statements).
(2) The 1996 results include expenses of $30.7 million related to the
write-off of acquired in-process technology and $4.7 million
relating to the reorganization plan approved in conjunction with
the NEIC and Teleclaims, Inc. acquisitions (See Note 4 of Notes
to the Consolidated Financial Statements).
(3) The above amounts reflect the impact of the Predecessor's merger
with First Data in June 1995. (See Notes 1 and 3 of Notes to the
Consolidated Financial Statements).
12
15
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
Although the Company believes that the assumptions underlying the
forward-looking statements contained herein are reasonable, any of the
assumptions could be inaccurate, and therefore, there can be no
assurances that the forward-looking statements included herein will
prove to be accurate. There are many factors that may cause actual
results to differ materially from those indicated by the forward-looking
statements, including, among others, competitive pressures, changes in
pricing policies, delays in product development, business conditions in
the marketplace, general economic conditions and the various risk
factors set forth in the Company's periodic reports filed with the
Securities and Exchange Commission. In light of the significant
uncertainties inherent in the forward-looking statements included
herein, the inclusion of such information should not be regarded as a
representation by the Company that the objectives and plans of the
Company will be achieved. The following discussion and analysis should
be read in conjunction with, and is qualified in its entirety by, the
Consolidated Financial Statements, including the notes thereto.
OVERVIEW
ENVOY Corporation (the "Company") is a leading provider of electronic
data interchange services to participants in the health care market, including
pharmacies, physicians, hospitals, dentists, billing services, commercial
insurance companies, managed care organizations, state and federal government
agencies and others.
The Company was incorporated in Tennessee in August 1994 as a
wholly-owned subsidiary of ENVOY Corporation, a Delaware corporation which was
formed in 1981 (the "Predecessor"). The Predecessor was formed to develop and
market electronic transaction processing services for the financial services and
health care markets. In June 1995, in order to facilitate the transfer of the
financial services business to First Data Corporation ("First Data"), the assets
and liabilities of the Predecessor associated with the health care business were
transferred to the Company. The capital stock of the Company then was
distributed to shareholders through a stock dividend (the "Distribution") and
the Predecessor was merged into First Data.
The Company has made several acquisitions since the beginning of 1996
(collectively, the "Acquired Businesses"), the most significant being the
acquisitions of National Electronic Information Corporation ("NEIC") and
Healthcare Data Interchange Corporation ("HDIC"). See Notes 4 and 7 of Notes to
the Consolidated Financial Statements. All acquisitions completed during 1997
and 1996 were accounted for under the purchase method of accounting and, as a
result, the Company has recorded the assets and liabilities of the Acquired
Businesses at their estimated fair values with the excess of the purchase price
over these amounts being recorded as goodwill. The financial statements for 1997
and 1996 reflect the operations of the Acquired Businesses for the periods after
their respective dates of acquisition.
The Company's revenues principally have been derived from transaction
processing services to the health care market which generally are paid for by
the health care providers or third-party payors. Revenues generally are earned
on a per transaction basis. In addition, total revenues include non-transaction
based revenues derived from some of the Acquired Businesses. This revenue
includes
13
16
maintenance, licensing and support activities, as well as the sale of ancillary
software and hardware products.
The Company's revenues generally are composed of two basic transaction
types (i) pharmacy and (ii) medical and other. The table below shows the number
of transactions processed by the Company for the periods presented:
YEAR ENDED DECEMBER 31,
-----------------------------------
1997 1996 1995
---------- --------- ----------
(IN THOUSANDS)
Pharmacy 597,609 478,526 363,084
Medical and other 215,437 132,724 15,308
-----------------------------------
Total 813,046 611,250 378,392
===================================
The transactions reflected above include the transactions of the Acquired
Businesses from the date of acquisition.
While pharmacy currently represents a majority of the Company's total
transactions, the fee associated with these transactions is significantly less
than that received for a medical transaction and as such pharmacy revenue
constituted less than 25% of the Company's total revenues in 1997. The rate of
growth of the Company's pharmacy business has slowed recently. For 1997, the
pharmacy business grew at approximately half the rate experienced in the
Company's medical business. As a result of this trend, the Company expects its
pharmacy business as presently conducted to represent a decreasing portion of
the Company's total revenues in the future. As the mix of the Company's business
changes, a decline in the growth rates associated with the Company's medical
business could have a material impact on the financial condition and operating
results of the Company. There can be no assurance that the mix of the Company's
business or growth rates will continue at their current level.
The Company continues to actively pursue the acquisition of health care
information businesses and other companies complementary to its business. The
Company's ability to successfully negotiate and close acquisitions will
materially impact the financial condition and operating results of the Company.
There can be no assurance that the Company will find attractive acquisition
candidates, be able to successfully finance and complete the acquisitions,
consolidate and integrate such businesses following the acquisition or
successfully operate them on a going forward basis.
Recent Development. On February 27, 1998, the Company completed
business combinations with the three companies operating the ExpressBill patient
statement processing and printing services business (collectively, the
"ExpressBill Companies"), pursuant to separate agreements and plans of merger
for an aggregate of 3.5 million shares of ENVOY Common Stock. See Note 19 of
Notes to Consolidated Financial Statements. It is anticipated that these
combinations will be accounted for as poolings of interests. Because these
combinations were consummated after the date of the consolidated financial
statements included in this Form 10-K, the accounts and results of operations of
the ExpressBill Companies are not included in the Company's consolidated
financial statements for the year ended December 31, 1997, and are not included
in the comments following in this Management's Discussion and Analysis of
Financial Condition and Results of Operations.
14
17
RESULTS OF OPERATIONS
The following table presents, for the periods indicated, the percentage
relationship certain statement of operations items bear to revenues.
YEAR ENDED
DECEMBER 31,
--------------------------------------
1997 1996 1995
------------ ------------- -----------
Revenues 100.0% 100.0% 100.0%
Cost of revenues 48.4 50.0 59.2
Selling, general and administrative
expenses 21.4 24.7 31.6
Depreciation and amortization 22.6 25.0 9.5
Merger and facilities integration costs 0 6.1 0
Write-off of acquired in-process
technology 33.4 40.1 0
EMC losses 0 0.7 0
-------------------------------------
Operating loss (25.8) (46.6) (.3)
Interest income 1.2 1.3 1.5
Interest expense (1.2) (3.5) (2.0)
-------------------------------------
Loss from continuing operations before
income taxes and loss in investee (25.8) (48.7) (0.9)
Income tax provision (benefit) (4.9) 2.1 0
Loss in investee 0 0 (6.8)
-------------------------------------
Loss from continuing operations (20.9)% (50.8)% (7.7)%
=====================================
FISCAL YEAR 1997 AS COMPARED WITH 1996
Revenues. Revenues for the year ended December 31, 1997 were $113.7
million compared to $76.6 million for the same period last year, an increase of
$37.1 million or 48.5%. The increase is attributable to internal transaction
revenue growth, an increase in non-transaction based sources of revenue, such as
software licenses, maintenance and support activities from certain of the
Acquired Businesses and additional revenues generated from the Acquired
Businesses.
Cost of Revenues. Cost of revenues includes the cost of communications,
computer operations, product development and customer support, as well as the
cost of hardware sales and rebates to third parties for transaction processing
volume. Cost of revenues in 1997 were $55.0 million compared to $38.3 million
for 1996, an increase of $16.7 million or 43.8%. The dollar increase is
attributable to the additional costs associated with the increased transaction
volume, the inclusion of the Acquired Businesses and increases in rebates paid
to third parties. The increase in rebates paid to third parties primarily
results from an increase in the mix of claims received from large third party
vendors and claim clearinghouses. Therefore, if mix shifts continue toward
larger vendors and clearinghouses, the Company expects rebates to represent an
increasing portion of its costs of sales. As a percentage of revenues, cost of
revenues improved to 48.4% in 1997 compared to 50.0% in 1996.
Selling, General and Administrative Expenses. Selling, general and
administrative expenses include marketing, finance, accounting and
administrative costs. Selling, general and administrative
15
18
expenses for 1997 were $24.3 million compared to $19.0 million in 1996, an
increase of 28.1%. The dollar increase is the result of the inclusion of the
Acquired Businesses and the required infrastructure to support the larger base
of revenues. As a percentage of revenues, selling, general and administrative
expenses decreased to 21.4% for 1997 compared to 24.7% for 1996. The improvement
is attributable to a larger base of revenues and the elimination of certain
duplicative costs realized in connection with the Acquired Businesses.
Depreciation and Amortization. Depreciation and amortization expense
relates primarily to host computers, communications equipment, goodwill and
other identifiable intangible assets. Depreciation and amortization expense for
1997 was $25.7 million compared to $19.2 million for 1996. The increase is
primarily the result of the amortization of $19.9 million in goodwill and other
intangibles related to the Acquired Businesses in 1997, compared with $14.6
million in 1996. Depreciation and amortization increased further as the result
of the additional investment in host computer systems and software to expand the
Company's transaction processing capabilities. At December 31, 1997, the Company
had goodwill of $32.7 million associated with the Acquired Businesses, remaining
to be amortized over periods of three to fifteen years following the
acquisitions. In addition, the Company had identified intangibles of $22.6
million, remaining to be amortized over two to nine year time periods, as
applicable.
Merger and Facility Integration Costs. The Company recognized merger
and facility integration costs in 1996 of $4.7 million related primarily to the
NEIC and Teleclaims, Inc. ("Teleclaims") acquisitions. These charges represent
costs incurred as a direct result of the plan to integrate NEIC and Teleclaims.
See Note 6 of Notes to the Consolidated Financial Statements. The Company
estimates that no future costs will be charged to merger and facility
integration costs related to NEIC and Teleclaims.
Write-off of Acquired in-Process Technology. The Company recorded
write-offs of acquired in-process technology of $38.0 million and $30.7 million
in 1997 and 1996, respectively. The 1997 write-offs related to the HDIC and DSS
acquisitions and the 1996 write-offs related to the NEIC and Teleclaims
acquisitions. Such amounts were charged to expense because the amounts related
to research and development that had not reached technological feasibility and
for which there was no alternative future use. See Note 4 of Notes to the
Consolidated Financial Statements.
Net Interest Expense. The Company recorded net interest expense of
$54,000 for 1997 compared to net interest expense of $1.6 million for 1996. The
Company incurred additional interest expense in 1997 resulting from the imputed
interest expense related to certain unfavorable contracts assumed as part of the
HDIC acquisition. See Note 4 of Notes to the Consolidated Financial Statements.
This additional interest expense was offset partially by interest income earned
on cash and cash equivalents. Net interest expense in 1996 resulted from
interest on outstanding borrowings under the Company's credit facilities and the
Company's $10.0 million in 9% convertible subordinated notes issued in June 1995
(the "Convertible Notes"). The borrowings, which consisted of a $25 million term
loan and approximately $12.9 million outstanding under the Company's revolving
credit facility, were repaid in 1996 with a portion of the proceeds from the
Company's August 1996 public offering of 3,320,000 shares of Common Stock. See
Note 14 of Notes to Consolidated Financial Statements. In a series of
transactions during 1997 and 1996, the Convertible Notes were converted into an
aggregate of 950,556 shares of the Company's Common Stock. Accordingly, no
Convertible Notes remain outstanding.
16
19
Income Tax Provision (Benefit). The Company's income tax benefit for
1997 was $5.6 million compared to a tax provision of $1.6 million in 1996. The
tax benefit recorded in 1997 reflects a deferred income tax benefit of $13.3
million associated with the $35.0 million charge for the write-off of acquired
in-process technology related to the HDIC acquisition. The income tax expense
recorded is based upon estimated taxable income. Amortization of certain
goodwill and identifiable intangibles are not deductible for income tax
purposes.
FISCAL YEAR 1996 AS COMPARED WITH 1995
Revenues. Revenues for the year ended December 31, 1996 were $76.6
million, an increase of $50.5 million or 193.5% over 1995. This increase is
primarily attributable to additional revenues generated from the Acquired
Businesses following the date of acquisition and a 31.8% increase in pharmacy
transactions over 1995.
Cost of Revenues. Cost of revenues in 1996 was $38.3 million compared
to $15.4 million in 1995, an increase of 149%. The dollar increase is
attributable to the inclusion of the Acquired Businesses' results and increased
transaction volume in the Company's pre-acquisition business. As a percentage of
revenues, cost of revenues was 50.0% in 1996 compared to 59.2% in 1995. The
improvement is attributable to the inclusion of the Acquired Businesses' results
following the date of acquisition which historically have experienced higher
gross profit margins than those of the Company's pre-acquisition business.
Selling, General and Administrative Expenses. Selling, general and
administrative expenses for 1996 were $18.9 million compared to $8.2 million in
1995, an increase of 130.5%. These expenses increased due to the inclusion of
the Acquired Businesses' results following the date of acquisition and the
additional costs associated with 1996 acquisitions. As a percentage of revenues,
selling, general and administrative expenses were 24.7% in 1996 compared to
31.6% in 1995. The improvement is attributable to a larger base of revenues as
well as the elimination of certain duplicative costs realized in connection with
the Acquired Businesses.
Depreciation and Amortization. Depreciation and amortization expense
for 1996 was $19.2 million compared to $2.5 million for 1995. The increase is
primarily the result of the amortization of goodwill and other intangibles
during 1996 of $14.6 million related to the Acquired Businesses. Depreciation
and amortization increased further as the result of the additional investment in
host computer systems during 1996 to expand the Company's transaction processing
capabilities. The Company will amortize goodwill of $37.5 million associated
with the Acquired Businesses over the three year period following the
acquisitions completed in 1996. In addition, ENVOY will amortize identified
intangibles of $29.7 million over two to nine year time periods, as applicable.
Merger and Facility Integration Costs. The Company recognized merger
and facility integration costs in 1996 of $4.7 million related to the NEIC and
Teleclaims acquisitions.
Write-off of acquired in-process technology. The Company recorded a
charge of $30.7 million in 1996 related to the NEIC and Teleclaims acquisitions.
These amounts were charged to expense because the amounts related to research
and development that had not reached technological feasibility and for which
there was no alternative future use.
17
20
EMC Losses. In January 1995, ENVOY acquired a 17.5% interest in
EMC*Express, Inc. ("EMC") and also entered into an agreement for the management
of EMC which required the Company to fund certain of EMC's operating costs in
the form of advances. The Company determined that it was probable an impairment
of its equity investment in EMC as of December 31, 1995 had occurred. As a
result, the Company recognized losses in 1996 of $540,000 relating to the
funding of EMC operating losses through the termination date of the management
agreement in March 1996. Based upon the Company's decision to terminate the
management agreement, the Company discontinued the equity method of accounting
for EMC and began accounting for the investment on a cost basis. Accordingly,
the loss related to EMC has been charged to operating expense. See Note 7 of
Notes to the Consolidated Financial Statements. Following the termination of the
management agreement, certain shareholders of EMC filed a lawsuit against the
Company asserting claims for breach of contract and negligent conduct. In
October 1996, the Company acquired the remaining 82.5% interest in EMC and
settled the related lawsuit. See Note 7 of Notes to Consolidated Financial
Statements.
Net Interest Expense. The Company recorded net interest expense in 1996
of $1.6 million compared to $133,000 of net interest expense for 1995. The
increase in interest expense is the result of increased borrowings under the
Company's bank credit facilities and interest associated with the Company's 9%
Convertible Notes, which more than offset interest income on the Company's
available cash.
Income Tax Provision. The Company's income tax provision in 1996 was
$1.6 million compared with no income tax expense in 1995. The income tax expense
recorded is based upon estimated taxable income. Amortization of certain
goodwill and identifiable intangibles are not deductible for income tax
purposes.
LIQUIDITY AND CAPITAL RESOURCES
The Company generally has incurred operating losses since its health
care transaction processing business commenced operations in 1989. The operating
losses historically resulted from the Company's substantial investment in its
health care transaction processing business coupled with a disproportionate
amount of overhead and fixed costs, and, more recently, from charges to merger
and facility integration costs and write off of acquired in-process technology
related to the Acquired Businesses. Prior to the sale of the financial
processing business in 1995, health care losses had been funded by earnings from
the Company's more mature financial business, which had a substantially higher
transaction volume and revenue base.
On August 7, 1997, the Company completed the acquisition of HDIC for
approximately $36.4 million and the assumption of certain liabilities. The HDIC
acquisition was financed through the Company's available cash. In addition, the
Company paid approximately $2.2 million to the former owners of DSS in February
1998 to satisfy a variable payment obligation in connection with that
acquisition. See Note 4 of Notes to the Consolidated Financial Statements.
Following these payments, the Company had available cash and cash equivalents of
approximately $7.7 million.
In February 1998, the Company issued 3.5 million shares of the
Company's Common Stock in connection with ExpressBill Companies' combinations.
See Note 19 of Notes to Consolidated Financial Statements. Also in February
1998, approximately 930,000 shares of the Company's Series B Preferred Stock
were converted into an equal number of shares of Common Stock. As a result of
18
21
these transactions, the number of shares of Common Stock outstanding increased
by approximately 4.4 million shares, or 27%, to 21.0 million shares.
The Company currently has no amounts outstanding under the Company's
$50 million revolving credit facility. Any outstanding borrowings made against
the credit facility would bear interest at a rate equal to the Base Rate (as
defined in the credit facility) or an index tied to LIBOR. Any amounts
outstanding under the credit facility will be due and payable in full on June
30, 2000. The credit facility contains financial covenants applicable to the
Company and its subsidiaries including ratios of debt to capital, annualized
EBITDA to annualized interest expense and certain other financial covenants
customarily included in a credit facility of this type. The Company and its
subsidiaries also are subject to certain restrictions relating to payment of
dividends, acquisitions, incurrence of debt and other restrictive provisions.
The credit facility is secured by substantially all of the assets of the Company
and its subsidiaries.
The Company purchases additional computer hardware and software
products from time to time as required to support the Company's business. The
Company incurred capital expenditures of $7.7 million and $4.8 million for 1997
and 1996, respectively, primarily for computer hardware and software products.
The Company currently estimates that total capital expenditures for 1998 will be
approximately $8 to $9 million.
The Company is expensing all costs associated with system changes
related to its Year 2000 Compliance Project as the costs are incurred through
operating cash flows. The Company estimates that the total cost of the Year 2000
expenses will be approximately $4.0 million, of which approximately $2.5 million
will be expensed during 1998. See "Management's Discussion and Analysis of
Financial Condition and Results of Operations -- Risk Factors - Year 2000
Compliance."
From time to time, the Company has engaged and will continue to engage
in acquisition discussions with other health care information businesses and
other companies complementary to its business. In the event the Company engages
in such acquisitions in the future, its currently available capital resources
may not be sufficient for such purposes and the Company may be required to incur
additional indebtedness or issue additional capital stock, which could result in
dilution to existing investors.
Based on current operations, anticipated capital needs to fund known
expenditures and current acquisitions, the Company believes its available cash,
cash flow from operations and the $50 million revolving credit facility will
provide the capital resources necessary to meet its liquidity and cash flow
requirements over the next twelve months, including the Company's current
short-term obligations. The Company believes that present funding sources will
provide the ability to meet long-term obligations as they mature. The Company's
available cash is invested in interest bearing securities with maturities of up
to 30 days.
RISK FACTORS
ENVOY's business is subject to numerous risks and uncertainties which
may affect its results of operations in the future and may cause such future
results to differ materially and adversely from projections included in or
underlying any forward-looking statements made by or on behalf of the Company.
Among the factors that may adversely affect the Company's business are:
19
22
Limited Operating History; Substantial Net Loss. The electronic health
care transaction processing industry is relatively new, and the Company's
operating history is relatively limited. ENVOY has experienced substantial net
losses, including net losses of approximately $23.8 million for the year ended
December 31, 1997, and has an accumulated deficit of approximately $65.8 million
as of December 31, 1997. Historically, operating losses incurred in the
Company's health care transaction processing business were funded by earnings
from the Company's financial processing business, which was sold in 1995. In
order to achieve profitability, the Company must successfully implement its
business strategy and increase its revenues, while controlling expenses. There
can be no assurance as to when or if the Company will achieve profitability.
Impact of Recent Acquisitions. As part of its strategy to maintain and
enhance its leadership position in the health care transaction processing
industry, the Company has completed several acquisitions, which have created a
significant expansion of ENVOY's overall business. The most significant
acquisitions of the Company include NEIC in March 1996, HDIC in August 1997 and
the business combinations with the ExpressBill Companies in February 1998. In
addition, the Company completed several other smaller acquisitions in 1997 and
1996. See Notes 4 and 19 of Notes to Consolidated Financial Statements. A brief
description of significant terms of certain of these acquisitions follows:
NEIC. The Company acquired NEIC for $94.3 million, including
fees, expenses and other costs associated with the acquisition. In
connection with the acquisition, the Company recognized a one-time
write off of acquired in-process technology of approximately $30.0
million. As a result of the NEIC acquisition, the Company is
amortizing $37.6 million of goodwill over a three year period, and
such amortization will adversely affect the Company's results of
operations through March 1999.
HDIC. In August 1997, the Company completed the acquisition of
HDIC for approximately $36.4 million and the assumption of certain
liabilities. The HDIC acquisition was financed through the Company's
available cash. In addition, the Company and AUSHC simultaneously
entered into a long-term services agreement under which AUSHC agreed
to use the Company as its single source clearinghouse and EDI network
for all AUSHC electronic health care transactions. Based upon
management's preliminary estimates, the Company recorded approximately
$16.1 million of goodwill and other identifiable intangible assets
related to the HDIC acquisition. Also recorded as part of the HDIC
acquisition was a one-time write-off of acquired in-process technology
of $35.0 million.
ExpressBill Companies. On February 27, 1998, the Company
completed business combinations with the three companies operating the
ExpressBill patient statement processing and printing services
businesses, for an aggregate of 3.5 million shares of ENVOY Common
Stock. The ExpressBill patient statement services include electronic
data transmission and formatting, statement printing and mailing
services for health care providers and practice management system
vendors. It is anticipated that these combinations will be accounted
for as poolings of interests.
There can be no assurance that the Company will be able to operate the Acquired
Businesses on a profitable basis, integrate the acquisitions with its existing
business or achieve operating synergies necessary to make the acquisitions
successful.
20
23
Customer Concentration. Primarily as a result of the HDIC acquisition,
the Company has one customer, Aetna U.S. Healthcare, Inc., that accounted for
approximately 15% of the Company's consolidated revenues for 1997. Prior to
1997, no customer accounted for more than 10% of the Company's revenues. Further
consolidation in the health care industry is likely to increase customer
concentration and may increase the Company's dependency on a limited number of
customers. In addition, a significant portion of NEIC's revenues has been
generated by five major insurance company payors who were shareholders of NEIC
before its acquisition by ENVOY. Although each of these carriers has continued
to use the Company's services after the acquisition of NEIC, they have no
minimum transaction commitment to the Company in the future and there can be no
assurance that the volume of business generated by these payors will not decline
or terminate. The loss of one or more significant customers could have a
material adverse effect on the Company's business, operating results or
financial condition.
Acquisition Strategy; Impact on Operating Results; Need for Capital.
The Company's strategy includes acquisitions of related health care information
businesses and other companies complementary to its business. The success of any
such acquisition will depend on many factors, including the Company's ability to
identify suitable acquisition candidates, the purchase price, the availability
and terms of financing, and management's ability to integrate effectively the
acquired services, technologies or businesses into the Company's operations.
Significant competition for acquisition opportunities exists in the health care
industry, which may significantly increase the costs of and decrease the
opportunities for acquisitions. Although ENVOY is actively pursuing potential
acquisitions, there can be no assurance that any acquisition will be
consummated. Further, to the extent that the Company is able to consummate an
acquisition, no assurance can be given that the Company will be able to operate
any acquired business profitably or otherwise successfully implement its
expansion strategy. ENVOY may finance future acquisitions through borrowings or
the issuance of debt or equity securities. Although the Company historically has
obtained financing on reasonable terms, there can be no assurances that future
lenders will extend credit, or extend credit on favorable terms. Further, any
issuance of equity securities could have a dilutive effect on the holders of
Common Stock. Such acquisitions may result in the recognition by the Company of
significant goodwill and increases in the amount of depreciation and
amortization expense which could adversely affect the Company's operating
results in future periods.
Year 2000 Compliance. The Year 2000 issue is primarily the result of
many computer programs and data structures' failure to include the century when
storing the representation for a year. During 1997, the Company developed and
began implementing a plan to ensure its computer systems will be Year 2000
compliant. An inventory of all relevant software and hardware was taken to
determine the state of compliance. Some systems require no changes because they
already conform to the 4-digit-year configuration which is the basis for the
Year 2000 issue. The remaining systems will be replaced or modified as needed to
properly display dates and perform date arithmetic. The Company anticipates
commencing testing with customers and other third parties in the second quarter
of 1998 with completion expected in June 1999. In addition to validating the
Company's internal program changes, this testing will determine the readiness of
the Company's customers to deal with the Year 2000 issue in their own systems.
Where warranted, the Company may assist customers in dealing with the changes
required to be compliant to ensure successful information processing for all
parties. Because of the nature of the Company's business, the success of the
Company's efforts may depend on the success of providers, payors and others in
dealing with the Year 2000 issue. Total cost of the Year 2000 projects is
estimated to be $4.0 million and is being funded through operating cash flows.
The Company is expensing all costs associated with these system changes as the
costs are
21
24
incurred. The Company estimates that Year 2000 expense for 1998 will
be approximately $2.5 million. If the Company is unable to deal successfully
with the Year 2000 issue, such inability could have a material adverse effect on
the Company's business, results of operation or financial condition.
Reliance on Data Centers. ENVOY's real-time electronic transaction
processing services depend on its host computer system which is contained in a
single data center facility. In addition, the Company's primary batch claims
processing capacity is outsourced to one vendor that processes claims through a
single computer center. The Company also operates a batch claims processing
center which is contained in a single data center facility in Oklahoma City,
Oklahoma for the processing of Blue Cross, Blue Shield, Medicare and Medicaid
claims. Although ENVOY is currently evaluating certain disaster recovery
alternatives, neither the real-time host computer system nor the Oklahoma City
batch claims center have a remote backup data center. There can be no assurance
that fire or other disaster affecting such data centers would not disable the
Company's respective systems or otherwise have a material adverse effect on the
Company's business, financial condition or results of operations. In addition, a
disruption in service from the vendor providing batch claims processing services
to the Company could have a material adverse effect on the Company's business,
operating results or financial condition.
Development of Electronic Processing in the Health Care Industry.
ENVOY's strategy anticipates that electronic processing of health care
transactions, including transactions involving clinical as well as financial
information, will win market acceptance and that providers and third-party
payors increasingly will use electronic processing networks for the processing
and transmission of data. Electronic transmission of health care transactions is
still developing, and complexities in the nature and types of transactions which
must be processed has hindered to some degree the development and acceptance of
electronic processing in this market. In addition, while the multiplicity of
claims forms and formats used by the many different third-party payors has
fostered the development of electronic clearinghouses, the standardization of
these claims formats, whether due to consolidation in the industry or otherwise,
could reduce the use of clearinghouses, including electronic clearinghouses.
There can be no assurance that continued conversion from paper-based transaction
processing to electronic transaction processing in the health care market will
occur or that, to the extent it does occur, health care providers and payors
will use independent networks such as those being developed by the Company.
Competition. ENVOY faces significant competition in the health care
sector of the electronic transaction processing market from companies that are
similarly specialized and also from companies that are involved in other, more
highly developed sectors of the electronic transaction processing market. The
Company also faces competition from other companies, such as vendors of provider
information management systems, which have added or may add their own
proprietary transaction processing systems to existing or future products. As a
result of such competition, the Company may be pressured to reduce per
transaction prices or eliminate per transaction prices altogether. If electronic
transaction processing becomes the standard for claims and information
processing, a number of larger and better capitalized entities may elect to
enter the industry and further increase competitive pricing pressures. Many of
the Company's existing and potential competitors are larger and have
significantly greater financial, marketing, technological and other resources
than the Company.
Availability of Direct Links. Certain third-party payors provide
electronic data transmission systems to health care providers that establish a
direct link between the provider and the payor,
22
25
bypassing third-party processors such as the Company. Any significant increase
in the utilization of direct links between health care providers and payors
would have a material adverse effect on the Company's business, operating
results and financial condition.
Uncertainty and Consolidation in the Health Care Industry. The health
care industry is subject to changing political, economic and regulatory
influences that may affect the procurement practices and operations of health
care industry participants. Federal and state legislatures periodically consider
programs to modify or amend the United States health care system at both the
federal and state level. These programs may contain proposals to increase
governmental involvement in health care, lower reimbursement rates or otherwise
change the environment in which health care industry participants operate.
Health care industry participants may react to these proposals and the
uncertainty surrounding such proposals by curtailing or deferring investments,
including investments in the Company's services and products. In addition, many
health care providers are consolidating to create larger health care delivery
organizations. This consolidation reduces the number of potential customers for
the Company's services, and the increased bargaining power of these
organizations could lead to reductions in the amounts paid for the Company's
services. Industry developments are increasing the amount of capitation-based
health care and reducing the need for providers to make claims of reimbursement
for products or services. Other health care information companies, such as
billing services and practice management vendors, which currently utilize the
Company's services, have developed or acquired transaction processing and
networking capabilities and may cease utilizing the Company's services in the
future. The impact of these developments in the health care industry is
difficult to predict and could have a material adverse effect on the Company's
business, operating results or financial condition.
Health Care Data Legislation. Two pieces of legislation currently being
considered at the federal level could impact the manner in which the Company
conducts its business. The Health Insurance Portability and Accountability Act
of 1996 mandates the use of standard transactions, standard identifiers,
security and other provisions by the year 2000. The Act specifically names
clearinghouses as the compliance facilitators for providers and payors.
Clearinghouses are given the freedom to utilize non-standard transactions and
convert them to the mandated standards on behalf of their clients. The Company
is preparing to comply with the mandated standards within three to six months
after their publication; however, the success of the Company's compliance
efforts may be dependent on the success of providers, payors and others in
dealing with the standards.
Legislation which imposes restrictions on the ability of third-party
processors to transmit certain patient data without specific patient consent
also recently has been introduced in the U.S. Congress. Such legislation, if
adopted, could adversely affect the ability of third-party processors to
transmit certain data, including treatment and clinical data. The impact of the
foregoing or other legislation is difficult to predict and could materially
adversely affect the Company's business, operating results or financial
condition.
Evolving Industry Standards and Rapid Technological Changes. The market
for the Company's business is characterized by rapidly changing technology,
evolving industry standards and frequent introduction of new and enhanced
products and services. ENVOY's success will depend upon its continued ability to
enhance its existing products and services, to introduce new products and
services on a timely and cost-effective basis to meet evolving customer
requirements, to achieve market acceptance for new products and services and to
respond to emerging industry standards and other technological changes. There
can be no assurance that the Company will be able to respond effectively
23
26
to technological changes or new industry standards. Moreover, there can be no
assurance that competitive products and services will not be developed, or that
any such competitive services will not have an adverse effect upon the Company's
business, operating results or financial condition.
Dependence on Technology; Risk of Infringement. ENVOY's ability to
compete effectively depends to a significant extent on its ability to protect
its proprietary information. The Company relies primarily on copyright, trade
secret and patent laws, confidentiality procedures and licensing arrangements to
protect its intellectual property rights. The Company generally enters into
confidentiality agreements with its consultants and employees and generally
limits access to and distribution of its technology, software and other
proprietary information. Although the Company intends to defend its intellectual
property, there can be no assurance that the steps taken by ENVOY to protect its
proprietary information will be adequate to prevent misappropriation of its
technology or that the Company's competitors will not independently develop
technologies that are substantially equivalent or superior to the Company's
technology. ENVOY is also subject to the risk of alleged infringement by ENVOY
of the intellectual property rights of others. Although the Company is not
currently aware of any pending or threatened infringement claims with respect to
the Company's current or future products, there can be no assurance that third
parties will not assert such claims. Any such claims could require the Company
to enter into license arrangements or could result in protracted and costly
litigation, regardless of the merits of such claims. No assurance can be given
that any necessary licenses will be available or that, if available, such
licenses can be obtained on commercially reasonable terms. Furthermore,
litigation may be necessary to enforce ENVOY's intellectual property rights, to
protect the Company's trade secrets, to determine the validity and scope of the
proprietary rights of others or to defend against claims of infringement. Such
litigation could result in substantial costs and diversion of resources and
could have a material adverse effect on the Company's business, operating
results or financial condition.
SEASONALITY
ENVOY's business is to some extent seasonal, with more revenues being
generated from September through March as a result of a greater number of health
care transactions arising in those months, while operating expenses tend to
remain relatively constant over the course of the year.
IMPACT OF INFLATION
Inflation has not had a significant impact on ENVOY's results of
operations to date.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The Company's financial statements required by Item 8 of Form 10-K are
located on pages F-1 through F-26 of this Annual Report on Form 10-K. In
addition, on page S-1 the supplemental financial schedules as required by Item 8
are provided. See Item 14.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
None.
24
27
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The Proxy Statement in connection with the Annual Meeting of
Shareholders to be held on June 4, 1998 will contain under the caption "Election
of Directors" and "Compliance with Section 16(a) of the Securities Exchange Act
of 1934" information required by Item 10 of Form 10-K as to directors and
certain executive officers of the Company and is incorporated herein by
reference. Pursuant to General Instruction G(3), certain information concerning
executive officers of the Company is included in Part I of this Form 10-K, under
the caption "Business - Executive Officers."
ITEM 11. EXECUTIVE COMPENSATION
The Proxy Statement in connection with the Annual Meeting of
Shareholders to be held on June 4, 1998 will contain under the caption
"Executive Compensation" information required by Item 11 of Form 10-K and is
incorporated herein by reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The Proxy Statement in connection with the Annual Meeting of
Shareholders to be held on June 4, 1998 will contain under the caption "Security
Ownership of Certain Beneficial Owners and Management" information required by
Item 12 of Form 10-K and is incorporated herein by reference.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
The Proxy Statement in connection with the Annual Meeting of
Shareholders to be held on June 4, 1998 will contain under the caption "Certain
Relationships and Related Transactions" information required by Item 13 of Form
10-K and is incorporated herein by reference.
25
28
PART IV
ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K
(a) 1. Financial Statements:
The following Consolidated Financial Statements are filed as part of
this Annual Report on Form 10-K:
Page Number
Description in Report
----------- -----------
Report of Independent Auditors F-1
Consolidated Balance Sheets, December 31, 1997 and December 31, 1996 F-2
Consolidated Statements of Operations for the years ended December 31, 1997,
1996 and 1995 F-4
Consolidated Statements of Shareholders' Equity for the years ended
December 31, 1997, 1996 and 1995 F-6
Consolidated Statements of Cash Flows for the years ended December 31,
1997, 1996 and 1995 F-7
Notes to Consolidated Financial Statements F-9
2. Financial Statement Schedules:
The following Financial Statement Schedule is filed as part of this
Annual Report on Form 10-K and should be read in conjunction with the Financial
Statements:
Page Number
Description in Report
----------- -----------
Schedule II - Valuation and Qualifying Accounts S-1
All schedules, except those set forth above, have been omitted since
the information required is included in the Consolidated Financial Statements or
Notes thereto, or they have been omitted as not applicable or not required.
3. Exhibits:
See Item 14(c) below.
(b) Reports on Form 8-K .
The Company filed a Current Report on Form 8-K/A on October 20, 1997
pursuant to Item 7(b) thereof with the Securities and Exchange Commission to
amend an earlier Form 8-K filed on August 22, 1997. The amendment was filed for
the purpose of including certain pro forma financial information relating to
the HDIC acquisition, which was omitted in the Form 8-K originally filed.
26
29
(c) Exhibits:
Exhibit No. Description
----------- -----------------------------------------------------------
2.1 Agreement and Plan of Distribution dated September 2, 1994,
as amended through December 16, 1994 (1)
2.2 Agreement and Plan of Merger dated November 30, 1995 by and
among ENVOY, Envoy Acquisition Corporation and NEIC (2)
2.3 Stock Purchase Agreement dated June 14, 1997 by and between
ENVOY Corporation and Advent Investments, Inc. (8)
2.4 Agreement and Plan of Merger dated as of February 23, 1998, by
and among ENVOY Corporation, Envoy Acquisition Corporation,
Professional Office Services, Inc. and Richard B. McIntyre (9)
2.5 Agreement and Plan of Merger dated as of February 23, 1998, by
and among ENVOY Corporation, Envoy Acquisition Corporation,
XpiData, Inc., Michael Marolf, Sr., Michael Marolf, Jr.,
Jeffrey Marolf and Lisa Marolf (9)
2.6 Agreement and Plan of Merger dated as of February 23, 1998,
by and among ENVOY Corporation, Envoy Acquisition Subsidiary,
Inc., Automated Revenue Management, Inc., Patrick J. McIntyre,
Terrence J. McIntyre and Michael S. McIntyre (9)
3.1 Charter, as amended (filed herewith is a Certificate of
Designations setting forth terms of Series B Convertible
Preferred Stock) (Charter as originally amended incorporated
by reference to the Registrant's Annual Report on Form 10-K
for the year ended December 31, 1995)
3.2 By-Laws (1)
4.1 Article IV of ENVOY's Charter, as amended (included in
Exhibit 3.1)
4.2 Shareholder Rights Plan (1)
4.3 Registration Rights Agreement dated March 6, 1996 by and among
ENVOY, General Atlantic Partners 25, L.P., GAP Coinvestment
Partners, L.P. and First Union Capital Partners, Inc. (3)
27
30
Exhibit No. Description
----------- ------------------------------------------------------------------
4.4 Registration Rights Agreement dated March 6, 1996 by and among
ENVOY and the Purchasers set forth on the signature pages
thereto (3)
4.5 Registration Rights Agreement dated February 27, 1998, by and
between ENVOY and the Persons set forth on the signature pages
thereto.
10.1 Amended and Restated Credit Agreement dated November 8, 1996 among
First Union National Bank of North Carolina, as agent, various
Lenders and ENVOY (4)
MANAGEMENT CONTRACT OR COMPENSATORY PLAN
10.2 Employment Agreement between ENVOY and Fred C. Goad, Jr. (1)
10.3 Employment Agreement between ENVOY and Jim D. Kever (1)
10.4 Employment Agreement between ENVOY and Kevin M. McNamara (5)
10.5 Employment Agreement between ENVOY and Harlan F. Seymour
10.6 Amended and Restated 1995 Employee Stock Incentive Plan (6)
10.7 Amended and Restated 1995 Stock Option Plan for Outside
Directors (6)
10.8 ENVOY Corporation Employee Stock Purchase Plan (7)
10.9 1998 ExpressBill Stock Option Plan
10.10 1992 Incentive Plan (1)
10.11 1992 Non-Employee Directors Stock Option Plan (1)
10.12 1990 Officer and Employee Stock Option Plan (1)
10.13 1990 Director Stock Option Plan (1)
10.14 1987 Stock Option Plan (1)
10.15 Form of Indemnification Agreement (1)
28
31
Exhibit No. Description
----------- ---------------------------------------------------------
21 Subsidiaries
23 Consent of Independent Auditors
27 Financial Data Schedule
- ------------
(1) Incorporated by reference to the Registrant's Form 10, as amended No.
0-25062.
(2) Incorporated by reference to the Registrant's Current Report on Form 8-K
filed December 7, 1995.
(3) Incorporated by reference to the Registrant's Current Report on Form 8-K
filed March 21, 1996.
(4) Incorporated by reference to the Registrant's Quarterly Report on Form 10-Q
for the quarter ended September 30, 1996.
(5) Incorporated by reference to the Registrant's Registration Statement on
Form S-3, as amended, No. 333-04433.
(6) Incorporated by reference to the Registrant's Annual Report on Form 10-K
for the year ended December 31, 1996.
(7) Incorporated by reference to the Registrant's Proxy Statement, dated April
30, 1997 for the Annual Meeting of Shareholders held June 19, 1997.
(8) Incorporated by reference to the Registrant's Current Report on Form 8-K
filed June 23, 1997.
(9) Incorporated by reference to the Registrant's Current Report on Form 8-K
filed February 25, 1998.
29
32
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this Annual Report on Form
10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
ENVOY CORPORATION
By: /s/ Fred C. Goad, Jr.
---------------------------------------
Fred C. Goad, Jr.
Chairman and Co-Chief Executive Officer
Pursuant to the requirements of Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
Signature Title Date
--------- ----- ----
/s/ Fred C. Goad, Jr. Chairman of the Board, Co-Chief March 6, 1998
- -------------------------------- Executive Officer and Director
Fred C. Goad, Jr.
/s/ Jim D. Kever Co-Chief Executive Officer, March 6, 1998
- -------------------------------- President and Director
Jim D. Kever
Senior Vice President, Chief March 6, 1998
/s/ Kevin M. McNamara Financial Officer (Principal
- -------------------------------- Financial and Accounting Officer)
Kevin M. McNamara and Director
/s/ William E. Ford Director March 6, 1998
- --------------------------------
William E. Ford
/s/ W. Marvin Gresham Director March 6, 1998
- --------------------------------
W. Marvin Gresham
/s/ Laurence E. Hirsch Director March 6, 1998
- --------------------------------
Laurence E. Hirsch
30
33
/s/ Richard A. McStay Director March 6, 1998
- --------------------------------
Richard A. McStay
/s/ Harlan F. Seymour Senior Vice President March 6, 1998
- -------------------------------- Corporate Strategy and
Harlan F. Seymour Development and Director
31
34
Report of Independent Auditors
Board of Directors and Shareholders
ENVOY Corporation
We have audited the accompanying consolidated balance sheets of ENVOY
Corporation and subsidiaries as of December 31, 1997 and 1996, and the related
consolidated statements of operations, shareholders' equity, and cash flows for
each of the three years in the period ended December 31, 1997. Our audits also
included the financial statement schedule listed in the Index at Item 14. These
financial statements and schedule are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements and schedule based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated financial position of ENVOY Corporation
and subsidiaries at December 31, 1997 and 1996, and the consolidated results of
their operations and their cash flows for each of the three years in the period
ended December 31, 1997, in conformity with generally accepted accounting
principles. Also, in our opinion, the related financial statement schedule, when
considered in relation to the basic financial statements taken as a whole,
presents fairly in all material respects the information set forth therein.
Ernst & Young LLP
Nashville, Tennessee
March 5, 1998
F-1
35
ENVOY Corporation
Consolidated Balance Sheets
(In thousands, except share data)
DECEMBER 31,
1997 1996
----------------------------------
Assets
Current assets:
Cash and cash equivalents $ 8,386 $ 36,430
Trade accounts receivable, less allowance for
doubtful accounts of $3,312 and $1,969 in
1997 and 1996, respectively 26,192 20,435
Inventories 1,936 2,586
Deferred income taxes 1,501 1,018
Other 1,694 2,947
----------------------------------
Total current assets 39,709 63,416
Property and equipment:
Equipment 32,696 24,627
Furniture and fixtures 2,166 3,004
Leasehold improvements 2,734 2,124
----------------------------------
37,596 29,755
Less accumulated depreciation and amortization (20,121) (14,402)
----------------------------------
17,475 15,353
Other assets:
Goodwill, net of amortization 32,719 26,981
Other intangibles, net of amortization 22,564 25,628
Deferred income taxes 10,018 0
Other 4,368 2,436
----------------------------------
Total assets $ 126,853 $ 133,814
==================================
See accompanying notes.
F-2
36
ENVOY Corporation
Consolidated Balance Sheets (continued)
(In thousands, except share data)
DECEMBER 31,
1997 1996
--------------------------------
Liabilities and shareholders' equity
Current liabilities:
Accounts payable $ 1,120 $ 4,828
Accrued expenses and other current liabilities 20,387 10,071
Current portion of long-term debt 0 93
--------------------------------
Total current liabilities 21,507 14,992
Long-term debt, less current portion 114 8,412
Deferred income taxes 0 1,965
Other non-current liabilities 9,163 0
Shareholders' equity:
Preferred stock--No par value; authorized,
12,000,000 shares; issued,
3,730,233 40,100 40,100
Common stock--No par value;
authorized, 48,000,000 shares;
issued, 16,575,822 and 15,354,531 in
1997 and 1996, respectively 114,586 103,199
Additional paid-in capital 7,155 7,155
Retained deficit (65,772) (42,009)
--------------------------------
Total shareholders' equity 96,069 108,445
--------------------------------
Total liabilities and shareholders' equity $126,853 $ 133,814
================================
See accompanying notes.
F-3
37
ENVOY Corporation
Consolidated Statements of Operations
(In thousands, except per share data)
YEAR ENDED DECEMBER 31,
1997 1996 1995
------------------------------------------------
Revenues $ 113,693 $ 76,584 $ 26,055
Operating costs and expenses:
Cost of revenues 55,023 38,252 15,435
Selling, general and administrative 24,281 18,950 8,243
Depreciation and amortization 25,663 19,177 2,468
Merger and facility integration costs 0 4,664 0
Write-off of acquired in-process technology 38,000 30,700 0
EMC losses 0 540 0
------------------------------------------------
Operating loss (29,274) (35,699) (91)
Other income (expense):
Interest income 1,312 1,032 380
Interest expense (1,366) (2,656) (513)
------------------------------------------------
(54) (1,624) (133)
------------------------------------------------
Loss from continuing operations
before income taxes and loss in investee (29,328) (37,323) (224)
Provision (benefit) for income taxes (5,565) 1,577 0
Loss in investee 0 0 (1,776)
------------------------------------------------
Loss from continuing operations (23,763) (38,900) (2,000)
Income from discontinued operations, net of
income taxes 0 0 30
First Data transaction expenses, including income taxes 0 0 (2,431)
------------------------------------------------
Loss from discontinued operations 0 0 (2,401)
------------------------------------------------
Net loss $ (23,763) $ (38,900) $ (4,401)
================================================
(Continued)
F-4
38
ENVOY Corporation
Consolidated Statements of Operations (continued)
(In thousands, except per share data)
DECEMBER 31,
1997 1996 1995
-----------------------------------------------
Loss per common share:
Continuing operations $(1.47) $(2.99) $(0.18)
Discontinued operations 0 0 (0.21)
-----------------------------------------------
Net loss per common share $(1.47) $(2.99) $(0.39)
===============================================
Weighted average shares outstanding 16,186 13,019 11,241
===============================================
See accompanying notes.
F-5
39
ENVOY Corporation
Consolidated Statements of Shareholders' Equity
(in thousands)
COMMON STOCK PREFERRED STOCK ADDITIONAL RETAINED TOTAL
---------------------------------------- PAID-IN EARNINGS DEFERRED SHAREHOLDERS'
SHARES AMOUNT SHARES AMOUNT CAPITAL (DEFICIT) COMPENSATION EQUITY
--------------------------------------------------------------------------------------------
Balance at December 31, 1994 11,018 $ 11,018 $35,190 $ 8,281 $ (1,264) $ 53,225
Stock options exercised 271 271 349 0 0 620
Income tax benefit realized on 0 0 46 0 0 46
exercise of stock options
First Data merger:
Stock option compensation charge 0 0 0 0 1,264 1,264
Equity transfer 0 0 (28,430) (6,989) 0 (35,419)
Net loss 0 0 0 (4,401) 0 (4,401)
--------------------------------------------------------------------------------------------
Balance at December 31, 1995 11,289 11,289 7,155 (3,109) 0 15,335
Stock options exercised 163 510 0 0 0 510
Stock issued in connection with
acquisitions 413 6,650 3,730 $40,100 0 0 0 46,750
Conversion of debt to common stock 170 1,786 0 0 0 0 0 1,786
Proceeds from issuance of stock 3,320 82,964 0 0 0 0 0 82,964
Net loss 0 0 0 0 0 (38,900) 0 (38,900)
--------------------------------------------------------------------------------------------
Balance at December 31, 1996 15,355 103,199 3,730 40,100 7,155 (42,009) 0 108,445
Stock options exercised 437 1,844 0 0 0 0 0 1,844
Income tax benefit realized on
exercise of stock options 0 1,249 0 0 0 0 0 1,249
Conversion of debt to common stock 781 8,214 0 0 0 0 0 8,214
Proceeds from issuance of stock 3 80 0 0 0 0 0 80
Net loss 0 0 0 0 0 (23,763) 0 (23,763)
--------------------------------------------------------------------------------------------
Balance at December 31, 1997 16,576 $114,586 3,730 $40,100 $ 7,155 $(65,772) $ 0 $ 96,069
============================================================================================
See accompanying notes.
F-6
40
ENVOY Corporation
Consolidated Statements of Cash Flows
(In thousands)
YEAR ENDED DECEMBER 31,
1997 1996 1995
----------------------------------------------------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (23,763) $ (38,900) $ (4,401)
Adjustments to reconcile net loss to net cash provided
by operating activities:
Depreciation and amortization 25,663 19,187 3,550
Stock option compensation expense 0 0 1,264
Provision for losses on accounts receivable 1,448 1,017 359
Deferred income tax provision (benefit) (12,466) 524 96
Write-off of certain assets and investments 38,000 32,281 820
Changes in assets and liabilities, net of First
Data transaction and acquired businesses:
Decrease (increase) in accounts receivable (6,507) (6,931) 1,185
Decrease (increase) in inventories 650 (440) (1,568)
Decrease (increase) in other current assets 1,053 (1,851) (619)
Increase (decrease) in accounts payable, accrued
expenses and other current liabilities (5,125) (2,619) 1,273
----------------------------------------------------
Net cash provided by operating activities 18,953 2,268 1,959
INVESTING ACTIVITIES
Net (increase) decrease in short-term investments 0 5,103 (5,103)
Purchases of property and equipment (7,677) (4,784) (7,970)
Decrease (increase) in other assets (1,998) 38 1,059
Investment in investee 0 0 (750)
Payments for businesses acquired, net of cash acquired of
$5,543 in 1996 (40,412) (93,744) 0
----------------------------------------------------
Net cash used in investing activities (50,087) (93,387) (12,764)
FINANCING ACTIVITIES
Proceeds from issuance of preferred stock 0 40,100 0
Proceeds from issuance of common stock 3,174 88,474 620
Proceeds from long-term debt 0 43,947 10,000
Payments on long-term debt (84) (43,994) (1,120)
Payment of deferred financing costs 0 (1,200) 0
Cash transferred in First Data transaction 0 0 (2,743)
----------------------------------------------------
Net cash provided by financing activities 3,090 127,327 6,757
----------------------------------------------------
Net increase (decrease) in cash and cash equivalents (28,044) 36,208 (4,048)
Cash and cash equivalents at beginning of year 36,430 222 4,270
----------------------------------------------------
Cash and cash equivalents at end of year $ 8,386 $ 36,430 $ 222
====================================================
F-7
41
ENVOY Corporation
Consolidated Statements of Cash Flows (continued)
(In thousands)
YEAR ENDED DECEMBER 31,
1997 1996 1995
------------------------------------------------
SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid $ (27) $ (2,141) $ (513)
Interest received $ 1,250 $ 1,024 $ 380
Income taxes paid $ (5,827) $ (141) $ (476)
NONCASH TRANSACTIONS
First Data Transaction:
Book Value of Assets Transferred, excluding cash $ 0 $ 0 $36,083
Liabilities transferred 0 0 (3,407)
Equity transferred 0 0 (35,419)
-----------------------------------------------
Cash transferred $ 0 $ 0 $(2,743)
===============================================
ACQUISITIONS
Working capital $ 0 $ 302 $ 0
Intangible assets 0 1,348 0
Common stock issued 0 (1,650) 0
-----------------------------------------------
Cash transferred $ 0 $ 0 $ 0
================================================
CONVERSION OF DEBT TO COMMON STOCK $ 8,214 $ 1,786 $ 0
=================================================
See accompanying notes.
F-8
42
ENVOY Corporation
Notes to Consolidated Financial Statements
1. ORGANIZATION
ENVOY Corporation, a Tennessee corporation (the "Company" or "New Envoy"), was
incorporated in August 1994 as a wholly-owned subsidiary of Envoy Corporation,
a Delaware corporation ("Old Envoy"), and through a stock dividend distribution
by Old Envoy of all of the outstanding shares of the common stock of New Envoy
(the "Distribution") the Company ceased to be a wholly-owned subsidiary of Old
Envoy. Immediately after the Distribution, Old Envoy was merged with and into
First Data Corporation ("First Data") (see Note 3). Old Envoy was formed in 1981
to develop and market electronic transaction processing services to capture and
transmit time critical information for the financial services and health care
markets. In 1995, the assets and liabilities of Old Envoy associated with the
electronic transaction processing for the health care markets and governmental
benefits programs were transferred to New Envoy. For accounting purposes, the
Company's financial statements for 1995 include financial information for its
predecessor, Old Envoy, with the financial services electronic processing
business (the "financial business") shown as discontinued operations. For
purposes of the notes to the consolidated financial statements, the "Company"
refers to Old Envoy and New Envoy for the period prior to June 6, 1995. The
Company currently provides electronic data interchange services to participants
in the health care market, including pharmacies, physicians, hospitals,
dentists, billing services, commercial insurance companies, managed care
organizations, state and federal government agencies and others throughout the
United States.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
PRINCIPLES OF CONSOLIDATION
The consolidated financial statements include the accounts of the Company and
its wholly-owned subsidiaries. Significant intercompany accounts and
transactions have been eliminated in consolidation.
CASH AND CASH EQUIVALENTS
The Company considers highly liquid investments with a maturity of three months
or less when purchased to be cash equivalents. The carrying amount approximates
fair value because of the short maturity of those instruments.
SHORT-TERM INVESTMENTS
Short-term investments include investments in fixed rate securities consisting
primarily of bonds and corporate notes. These investments have maturity dates of
one to five years from the date of purchase and are accounted for in accordance
with Statement of Financial Accounting Standards ("SFAS") No. 115, "Accounting
for Certain Investments in Debt and Equity Securities." All short-term
investments were sold prior to December 31, 1996.
Proceeds, gross realized gains and gross realized losses from the sale of
available-for-sale securities were $6,126,000, $1,911, and $39,138,
respectively, in 1996 and $9,470,000, $288,000, and $9,000, respectively, in
1995. The cost of securities sold is based on the specific identification
method.
F-9
43
ENVOY Corporation
Notes to Consolidated Financial Statements
CONCENTRATION OF CREDIT RISK
The Company has one customer that accounted for approximately 15% of the
Company's consolidated revenues for 1997 and accounted for approximately 21% of
consolidated accounts receivable. No single customer accounted for more than 10%
of consolidated revenues in 1996 or 1995.
INVENTORIES
Inventories which consist of point-of-service terminals and parts, are stated at
the lower of cost (first-in, first-out method) or market.
PROPERTY AND EQUIPMENT
Property and equipment is recorded at cost. Depreciation is provided over the
estimated lives of the respective assets on the straight-line basis principally
over five to seven years. Depreciation expense totaled $5,734,000, $4,614,000
and $2,418,000 for 1997, 1996 and 1995, respectively.
OTHER ASSETS
Other assets, including goodwill, customer lists, covenants not to compete,
developed technology, assembled work force, and submitter/payor relationships,
are being amortized on a straight-line basis over two to fifteen year time
periods, as applicable. The Company periodically evaluates the recoverability of
such intangibles resulting from business acquisitions and measures the amount of
impairment, if any, by assessing current and future levels of income and cash
flows as well as other factors, such as business trends and prospects and market
and economic conditions. Amortization expense related to such intangible assets
for 1997, 1996 and 1995 was $19,929,000, $14,563,000 and $38,000, respectively.
At December 31, 1997 and 1996, accumulated amortization of intangible assets was
$34,420,000 and $14,563,000, respectively.
REVENUE RECOGNITION
Processing services revenue is recognized as the transactions are processed.
Receivables generally are due within 30 days and do not require collateral.
LOSS PER COMMON SHARE
In 1997, the Company adopted the provisions of SFAS No. 128, Earnings per Share.
SFAS 128 replaced the calculation of primary and fully diluted earnings per
share with basic and diluted earnings per share. Unlike primary earnings per
share, basic earnings per share excludes any dilutive effects of options,
warrants and convertible securities. The adoption of SFAS No. 128 has not had a
significant impact on the Company's computation of earnings per share for the
current or prior periods.
F-10
44
ENVOY Corporation
Notes to Consolidated Financial Statements
RESEARCH AND DEVELOPMENT
Research and development expenses of $1,931,000 in 1997, $1,654,000 in 1996 and
$1,419,000 in 1995 were charged to cost of revenue as incurred until
technological feasibility had been established for the product. Thereafter, all
software development costs are capitalized until the products are available for
general use by customers. The Company has not capitalized any significant
software costs to date.
INCOME TAXES
Income taxes have been provided using the liability method in accordance with
SFAS No. 109, "Accounting for Income Taxes."
USE OF ESTIMATES
The preparation of the financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the amounts reported in the financial statements and
accompanying notes. Actual results could differ from those estimates.
STOCK BASED COMPENSATION
Under various benefit plans, the Company grants stock options for a fixed number
of shares to employees and directors with an exercise price which approximates
the fair value of the shares at the date of grant. The Company accounts for
stock option grants in accordance with Accounting Principles Board ("APB")
Opinion No. 25, ("APB No. 25") "Accounting for Stock Issued to Employees," and,
accordingly, recognizes no compensation expense for the stock option grants.
RECLASSIFICATIONS
Certain reclassifications have been made in the 1996 and 1995 consolidated
financial statements to conform with the 1997 presentation.
3. DISCONTINUED OPERATIONS--TRANSACTION WITH FIRST DATA CORPORATION
On June 6, 1995, the Company completed a merger of its financial transaction
processing business with First Data (the "First Data Merger"). Pursuant to a
management services agreement entered into in connection with the First Data
Merger, the Company was entitled to receive a fee from First Data of $1,500,000
per annum, payable in quarterly installments of $375,000, during the first two
years following the First Data Merger. Management fees of $650,000, $1,500,000
and $850,000 for the years ended December 31, 1997, 1996 and 1995 are classified
in revenues in the consolidated statements of operations.
The net assets of the financial business were merged with and into First Data
and were accounted for as discontinued operations.
Revenues of the financial business were $12,828,000 for the period January 1,
1995 through June 6, 1995.
F-11
45
ENVOY Corporation
Notes to Consolidated Financial Statements
The Company incurred $1,997,000 in expense related to the Distribution and First
Data Merger for the year ended December 31, 1995. These expenses consisted
primarily of legal, accounting and financial advisor fees. As set forth in the
merger agreement, First Data paid 50% of the costs of the transactions up to a
maximum expense to First Data of $2,000,000. The $1,997,000 incurred by the
Company is net of the $2,000,000 paid by First Data. The costs associated with
the First Data Merger have been included in discontinued operations including
applicable income taxes of $434,000 for the year ended December 31, 1995 and
reflect the reversal of tax benefits previously recognized for such charges.
4. ACQUISITIONS
Each of the following acquisitions was accounted for under the purchase method
of accounting, applying the provisions of APB Opinion No. 16 ("APB 16") and, as
a result, the Company recorded the assets and liabilities of the acquired
companies at their estimated fair values with the excess of the purchase price
over these amounts being recorded as goodwill. Actual allocations of goodwill
and identifiable intangibles will be based upon further studies and may change
during the allocation period, generally one year following the date of
acquisition. The financial statements reflect the operations of the acquired
businesses for the periods after their respective dates of acquisition.
NATIONAL ELECTRONIC INFORMATION CORPORATION ("NEIC")
On March 6, 1996, the Company's shareholders approved the acquisition of NEIC
for an aggregate purchase price of approximately $94,301,000, consisting of
$88,354,000 paid to the NEIC stockholders and certain other transaction and
acquisition costs of $5,947,000. The Company recorded $37,631,000 in goodwill
and $19,600,000 of identifiable intangible assets related to the NEIC
acquisition.
In connection with the NEIC acquisition, the Company incurred a one time
write-off of acquired in-process technology of $30,000,000. Such amount was
charged to expense in 1996 because this amount relates to research and
development that had not reached technological feasibility and for which there
was no alternative future use.
The NEIC acquisition was financed through equity and debt financing. An
aggregate of 3,730,233 shares of the Company's Series B Convertible Preferred
Stock were issued to three investors for a total purchase price of $40,100,000.
Additionally, the Company issued 333,333 shares of the Company's common stock
("Common Stock") to various investors for an aggregate purchase price of
$5,000,000. The Company also entered into a credit agreement, whereby the
Company obtained $50,000,000 in bank financing in the form of a $25,000,000
revolving credit facility and a $25,000,000 term loan. An additional 840 shares
of NEIC cumulative redeemable preferred stock were redeemed by the Company on
August 1, 1996 at a redemption price of approximately $2,200,000.
TELECLAIMS, INC. ("TELECLAIMS")
On March 1, 1996, the Company acquired all the issued and outstanding capital
stock of Teleclaims in exchange for 73,242 shares of Common Stock yielding a
purchase price of approximately $1,500,000. Goodwill and identifiable
intangibles in the amount of $648,000 were recorded in connection with the
acquisition of Teleclaims. Also recorded as part of the Teleclaims acquisition
was a
F-12
46
ENVOY Corporation
Notes to Consolidated Financial Statements
one time write-off of acquired in-process technology of $700,000. Such
amount was charged to expense in 1996 because this amount related to research
and development that had not reached technological feasibility and for which
there was no alternative future use.
NATIONAL VERIFICATION SYSTEMS, L. P. ("NVS")
On September 13, 1996, the Company completed the acquisition of certain assets
and liabilities of NVS for $2,150,000 in cash and the assumption of certain
liabilities. Goodwill and other identifiable intangible assets in the amount of
$1,864,000 were recorded in connection with the NVS acquisition.
PROFESSIONAL OFFICE SYSTEMS, INC. ("POSI")
On October 31, 1996, the Company acquired all the issued and outstanding capital
stock of POSI, the electronic data interchange clearinghouse for Blue Cross and
Blue Shield of the National Capital Area, for approximately $6,400,000 in cash
and the assumption of certain liabilities. Goodwill and identifiable intangibles
in the amount of $6,742,000 were recorded in connection with the acquisition of
POSI.
DIVERSE SOFTWARE SOLUTIONS, INC. ("DSS")
On March 11, 1997, the Company completed the acquisition of certain assets of
DSS for $4,000,000 in cash, plus a variable payout based upon revenue earned
during a specified period following the acquisition, and the assumption of
certain liabilities. At December 31, 1997, the Company has recorded a liability
of $2,200,000 related to the variable payments, which were paid in February
1998. This obligation is included in accrued expenses at December 31, 1997.
Based on management's preliminary estimates, the Company recorded $5,164,000 of
goodwill and other identifiable intangible assets related to the DSS
acquisition. Also recorded as part of the DSS acquisition was a one-time
write-off of acquired in-process technology of $3,000,000. Such amount was
charged to expense in 1997 because this amount related to research and
development that had not reached technological feasibility and for which there
was no alternative future use.
HEALTHCARE DATA INTERCHANGE CORPORATION ("HDIC")
On August 7, 1997, the Company acquired all the issued and outstanding capital
stock of HDIC, the electronic data interchange ("EDI") health care services
subsidiary of Aetna U.S. Healthcare, Inc. ("AUSHC"), for approximately
$36,400,000 in cash and the assumption of approximately $14,800,000 in
liabilities including approximately $13,800,000 relating to the assumption of
unfavorable contracts. At December 31, 1997, the remaining liability for
unfavorable contracts was $13,073,000, with $9,163,000 classified as a
non-current liability, and $3,910,000 classified as a current liability in
accrued expenses and other current liabilities. In addition, the Company and
AUSHC simultaneously entered into a long-term services agreement under which
AUSHC has agreed to use the Company as its single source clearinghouse and EDI
network for all AUSHC electronic health care transactions. Based upon
management's preliminary estimates, the Company recorded approximately
$16,100,000 for goodwill and other identifiable intangible assets related to the
HDIC acquisition. Also recorded as part of the HDIC acquisition was a one-time
write-off of acquired in-process technology of $35,000,000. Such amount was
charged to expense in 1997 because this amount related to research and
development that had not reached technological feasibility and for which there
was no alternative future use.
F-13
47
ENVOY Corporation
Notes to Consolidated Financial Statements
The following presents unaudited pro forma results of operations (including the
one-time write-off of acquired in-process technology and all merger and facility
integration costs) for the years ended December 31, 1997, 1996 and 1995 assuming
all acquisitions, including EMC*Express, Inc. ("EMC") (see Note 7), had been
consummated at the beginning of the periods presented (in thousands, except per
share data):
YEAR ENDED DECEMBER 31,
1997 1996 1995
----------------------------------------------
Revenues $ 120,187 $ 101,990 $ 78,962
Net loss (27,847) (46,535) (40,309)
Net loss per common share (1.72) (3.50) (3.46)
5. SALE OF THE GOVERNMENT SERVICES BUSINESS
On September 16, 1997, the Company completed the sale of substantially all of
the assets related to the Company's hunting and fishing licenses and electronic
benefit transfer business (collectively "the Government Services Business") for
(i) $500,000 payable in the form of a promissory note due and payable in full on
August 31, 1999 and (ii) certain contingent payment amounts based upon the
achievement of specified future operating results of the Government Services
Business. The Company recorded a gain of $500,000 related to the sale of the
Government Services Business in 1997. The results of operations of the
Government Services Business are included in the Company's consolidated
statements of operations through the date of disposition.
F-14
48
ENVOY Corporation
Notes to Consolidated Financial Statements
6. MERGER AND FACILITY INTEGRATION COSTS
As a result of the acquisitions of NEIC and Teleclaims in March 1996, the
Company approved a plan that reorganized certain of its operations, personnel
and facilities to gain the effects of potential cost savings and operating
synergies. The cost of this plan to integrate the acquired companies was
recognized as incurred in accordance with the guidance set forth in Emerging
Issues Task Force Issue 94-3, "Liability Recognition for Certain Employee
Termination Benefits and Other Costs to Exit an Activity (including Certain
Costs Incurred in a Restructuring)" and was not part of the purchase price
allocation. The costs for the year ended December 31, 1996 associated with this
plan of $4,664,000 represent exit costs associated with lease terminations,
personnel costs, writedowns of impaired assets and other related costs that were
incurred as a direct result of the plan and were classified as merger and
facility integration costs in the consolidated statements of operations. The
employee groups terminated include accounting, marketing and certain areas of
the systems and operations departments. The number of employees terminated was
approximately 120. Amounts charged against the liability for 1997 and 1996 were
approximately $385,000 and $1,434,000, respectively.
7. LOSS IN INVESTEE
On January 28, 1995, the Company purchased 17.5% of the capital stock of EMC for
approximately $570,000. In connection therewith, the Company paid $250,000 for
an option to purchase the remainder of the capital stock of EMC (the "Option"),
and also entered into a management agreement to provide management services to
EMC (the "Management Agreement"). Under the terms of the Management Agreement,
the Company agreed to fund certain operating costs of EMC in the form of
advances. The Management Agreement could be terminated by the Company at any
time on 60 days written notice, at which time the Option would be terminated.
The Company gave notice to terminate the Management Agreement on January 31,
1996. As a result of the termination notice and other facts and circumstances,
the Company determined that it was probable an impairment to its investment had
occurred. Accordingly, the Company recorded an adjustment in the fourth quarter
of 1995 in the amount of $1,637,000 to recognize an impairment in the carrying
value of its investment and cumulative advances. During 1995, the Company
recognized losses for its initial investment and option aggregating $820,000,
advances of $817,000 and equity losses of $139,000 for a total loss in the EMC
investment of $1,776,000.
Based on the Company's decision to terminate the Management Agreement, the
Company discontinued the equity method of accounting for EMC and began
accounting for the investment on a cost basis during the fourth quarter of 1995.
Accordingly, the funding of EMC's operating costs in 1996 were charged to
operating expenses. The Company was committed through March 31, 1996 to continue
to fund certain operating costs of EMC. The amounts disbursed for the funding of
these costs during the first two quarters of 1996 were $540,000.
Following the termination of the Management Agreement and the Option, certain
shareholders of EMC filed a lawsuit in March 1996 against the Company asserting
claims for breach of contract and negligent conduct. On October 18, 1996, the
Company settled this lawsuit for $300,000. Concurrent with the settlement of the
lawsuit, the Company completed the acquisition of the remaining 82.5% interest
in EMC for approximately $2,000,000 in cash. The EMC acquisition was accounted
for under the purchase method of accounting applying the provisions of APB No.
16 and, as a result, the Company recorded the assets and liabilities at their
estimated fair values. The Company recorded $1,954,000 of other identifiable
intangible assets related to the EMC acquisition. The operations of EMC are
included in the consolidated statements of operations from the date of
acquisition.
F-15
49
ENVOY Corporation
Notes to Consolidated Financial Statements
8. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current liabilities consists of the following (in
thousands):
DECEMBER 31,
1997 1996
-------------------------------
Current portion of liability for unfavorable contracts $ 3,910 $ 0
Liability to former owners of DSS 2,200 0
Unearned income 1,942 0
Accrued communication expense 1,982 2,259
Accrued income taxes 1,208 1,789
Accrued salaries and benefits 1,931 1,454
Accrued vendor incentives 1,731 1,085
Other 5,483 3,484
-------------------------------
$ 20,387 $ 10,071
===============================
The liability to former owners of DSS is related to the DSS acquisition, and the
liability for unfavorable contracts is related to the HDIC acquisition (see
Note 4).
9. LONG-TERM DEBT
In connection with the Distribution and First Data Merger, the Company entered
into a $10,000,000 note agreement with First Data on June 6, 1995 (the
"Convertible Note"). The Convertible Note was convertible, at the option of the
holder, into fully paid and nonassessable shares of Common Stock, on terms
subject to adjustment for stock dividends, subdivision, and combinations,
subsequent issuances of Common Stock, issuances of certain rights, stock
purchase rights or convertible securities and certain issuer tender offers.
During 1996, First Data sold the Convertible Note to an unrelated third party
for $13,500,000.
On November 7, 1996, the Company filed a registration statement with the
Securities and Exchange Commission covering the offering of 321,289 shares of
Common Stock pursuant to the demand of the current holders of the Convertible
Note under a Registration Rights Agreement dated June 6, 1995. The Company was
advised by the holders of the Convertible Notes that they intended to convert
$3,380,000 principal amount of the Convertible Notes into 321,289 shares of
Common Stock to permit their sale pursuant to the registration statement. Prior
to the termination of the registration statement on May 19, 1997, an aggregate
of $2,245,000 in principal amount of the convertible Notes was converted into
213,389 shares of Common Stock and sold pursuant to the registration statement.
In a series of unrelated transactions, the remaining $7,755,000 in principal
amount of the Convertible Notes was converted into 737,167 shares of Common
Stock through June 1997. Accordingly, no Convertible Notes remain outstanding.
F-16
50
ENVOY Corporation
Notes to Consolidated Financial Statements
In November 1996, the Company amended its revolving credit facility to increase
the amount of credit available thereunder to $50,000,000. The Company currently
has no amounts outstanding under the amended credit facility. Any outstanding
borrowings made against the amended credit facility would bear interest at a
rate equal to the Base Rate (as defined in the amended credit facility) or
LIBOR. The amended credit facility expires June 30, 2000. The amended credit
facility contains financial covenants applicable to the Company including ratios
of debt to capital, annualized EBITDA to annualized interest expense,
restrictions on payment of dividends, and certain other financial covenants
customarily included in a credit facility of this type. The Company and its
subsidiaries also are subject to certain restrictions relating to payment of
dividends, acquisitions, incurrence of debt and other restrictive provisions.
The amended credit facility is secured by substantially all of the assets of the
Company and its subsidiaries.
10. LEASES AND COMMITMENTS
The Company leases certain equipment and office space under operating leases.
Rental expense incurred under the leases during the years ended December 31,
1997, 1996 and 1995 was approximately $1,499,000, $1,596,000 and $1,095,000,
respectively.
Future minimum rental payments at December 31, 1997 under operating lease
arrangements are as follows (in thousands):
1998 $ 1,574
1999 1,476
2000 1,195
2001 766
2002 203
Thereafter 453
==============
Total minimum lease payments $ 5,667
==============
11. STOCK INCENTIVE PLANS
The Company has elected to follow APB No. 25 and related Interpretations in
accounting for its stock options because, as discussed below, the alternative
fair value accounting provided for under SFAS No. 123, "Accounting for
Stock-Based Compensation," requires use of option valuation models that were not
developed for use in valuing stock options. Under APB No. 25, because the
exercise price of the Company's stock options equals the market price of the
underlying stock on the date of grant, no compensation expense is recognized.
F-17
51
ENVOY Corporation
Notes to Consolidated Financial Statements
At December 31, 1997, the Company had reserved 4,214,640 shares of Common Stock
for issuance in connection with the stock option plans. Summaries of stock
options outstanding are as follows:
WEIGHTED-AVERAGE
NUMBER OF SHARES OPTION PRICE PER SHARE EXERCISE PRICE
---------------------------------------------------------------
Outstanding, December 31, 1994 1,477,000 $ 1.83 - $ 7.00 $ 2.61
Granted 1,829,000 2.19 - 18.00 9.54
Exercised (271,000) 1.83 - 3.79 2.28
---------------------------------------------------------------
Outstanding, December 31, 1995 3,035,000 1.83 - 18.00 6.81
Granted 625,000 20.25 - 40.25 24.53
Exercised (163,000) 1.83 - 7.75 3.12
Canceled (268,000) 7.75 - 10.00 9.02
---------------------------------------------------------------
Outstanding, December 31, 1996 3,229,000 1.83 - 40.25 10.25
Granted 834,000 21.25 - 36.75 23.22
Exercised (437,000) 1.83 - 20.75 4.25
Canceled (224,000) 7.75 - 30.00 19.92
---------------------------------------------------------------
Outstanding, December 31, 1997 3,402,000 $ 1.83 - $37.00 $ 13.58
===============================================================
The number of stock options exercisable and the weighted average exercise price
of these options was 1,147,500 and $5.76 and 1,254,000 and $3.47 at December 31,
1997 and 1996, respectively. The weighted-average fair value of options granted
during 1997 and 1996 was $10.96 and $13.93, respectively. The weighted-average
remaining contractual life of those options is 5 years.
The Company's Amended and Restated 1995 Employee Stock Incentive Plan has
authorized the grant of options for up to 3,000,000 shares of Common Stock. All
options granted have 10 year terms from the grant date and vest over periods
from one to five years from the date of grant. At December 31, 1997, options for
the purchase of 2,691,000 shares were outstanding under this plan.
The Company's Amended and Restated 1995 Stock Option Plan for Outside Directors
has authorized the grant of options to the Company's non-employee directors for
up to 60,000 shares of Common Stock. All options granted have 10 year terms and
become fully exercisable one year from the date of grant. At December 31, 1997,
options for the purchase of 24,000 shares were outstanding under this plan.
Prior to the First Data Merger, Old Envoy had outstanding non-qualified stock
options for the purchase of 1,214,640 shares of Common Stock. The grants were
made under the 1987 Stock Option Plan, the 1990 Director Stock Option Plan, the
1990 Officer and Employee Stock Option Plan, the 1992 Non-Employee Directors'
Plan and the 1992 Incentive Plan. Because all of these grants
F-18
52
ENVOY Corporation
Notes to Consolidated Financial Statements
were made prior to the First Data Merger, no further grants may be made under
these plans. All options granted thereunder have 10 year terms from the grant
date. In connection with the Distribution and First Data Merger, each holder of
an outstanding option to purchase shares of Old Envoy common stock (an "Old
Envoy Option") received an option to purchase an equal number of shares of
Common Stock (a "New Envoy Option"). The exercise price of the New Envoy Option
is equal to a percentage (the "distribution percentage") of the exercise price
of the Old Envoy Option. The distribution percentage was established based upon
the market prices of Common Stock and Old Envoy Common Stock as determined by
the ratio of (i) the average of the closing prices of Common Stock on the three
trading days immediately following the First Data Merger to (ii) the closing
price of Old Envoy Common Stock immediately prior to the First Data Merger. The
distribution percentage was 33.33% and resulted in a retroactive correspondingly
downward adjustment of each New Envoy Option. The distribution percentage
adjustment was designed to place the holder of an Old Envoy Option in the same
economic position after the First Data Merger as before the First Data Merger.
At December 31, 1997, options for the purchase of 687,000 shares were
outstanding and fully exercisable under these plans.
The Compensation Committee of the Board of Directors amended the 1992 Incentive
Plan in August 1994 to provide that all options thereunder would vest
immediately preceding the expiration of such option grant or earlier upon the
attainment of certain performance criteria. This amendment resulted in the
recording of deferred compensation and additional paid-in capital of
approximately $1,974,000. The deferred compensation was recognized as an expense
over the vesting period. As a result of the First Data Merger (see Note 3), the
vesting of all outstanding options was accelerated and all options became fully
vested as of the effective date of the First Data Merger. Accordingly, during
the year ended December 31, 1995, the remaining deferred compensation expense of
$1,264,000 was recognized.
Pro forma information regarding net loss and loss per share is required by SFAS
No. 123, which also requires that the information be determined as if the
Company has accounted for its employee stock options granted subsequent to
December 31, 1994 under the fair value method. The fair value for these options
was estimated at the date of grant using a Black-Scholes option pricing model
with the following weighted-average assumptions for 1997 and 1996, respectively:
risk-free interest rates of 5.77% and ranging from 5.36% to 6.69%; no dividend
yield; volatility factors of the expected market price of Common Stock ranging
from .436 to .455 and .385 to .419, respectively; and a weighted-average
expected life of the option of 5 years.
The Black-Scholes option valuation model was developed for use in estimating the
fair value of traded options which have no vesting restrictions and are fully
transferable. In addition, option valuation models require the input of highly
subjective assumptions including the expected stock price volatility. Because
the Company's stock options have characteristics significantly different from
those of traded options, and because changes in the subjective input assumptions
can materially affect the fair value estimate, in management's opinion, the
existing models do not necessarily provide a reliable single measure of the fair
value of its stock options.
F-19
53
ENVOY Corporation
Notes to Consolidated Financial Statements
For purposes of pro forma disclosures, the estimated fair value of the options
is amortized to expense over the options' vesting period. The Company's pro
forma information follows (in thousands, except for loss per share information):
1997 1996 1995
----------------------------------------------
Pro forma net loss $ (27,000) $ (40,640) $ (4,838)
Pro forma loss per common share (1.67) (3.12) (.43)
Because SFAS No. 123 is applicable only to options granted subsequent to
December 31, 1994, its pro forma effect will not be fully reflected until the
new rules are applied to all outstanding awards.
The Company implemented the ENVOY Corporation Employee Stock Purchase Plan (the
"ESPP") effective July 1, 1997, at which time participating employees became
entitled to purchase Common Stock at a discounted price through accumulated
payroll deductions. Under the terms of the ESPP, the purchase price of the
Common Stock for participating employees will be the lesser of (i) 85% of the
closing market price of the Common Stock on the last trading day of each
quarterly enrollment period or (ii) 85% of the closing market price of the
Common Stock on the first trading day of each quarterly enrollment period. The
Company has reserved 1,000,000 shares of Common Stock for issuance under the
ESPP. As of December 31, 1997, approximately 3,000 shares had been issued under
the ESPP.
12. PREFERRED STOCK
In March 1996, the Company issued 3,730,233 shares of Series B Preferred Stock
("Preferred Stock") in connection with the NEIC acquisition (see Note 4). The
Preferred Stock is recorded in the accompanying consolidated balance sheet at
its liquidation preference of $10.75 per share, or $40,100,000 in the aggregate.
Each share of Preferred Stock is convertible into 1 share of Common Stock at any
time. Each share of Preferred Stock shall be entitled to vote on all matters
that the holders of Common Stock are entitled to vote upon, on an
as-if-converted basis, and shall be entitled to vote as a class with respect to
actions adverse to any rights of the Preferred Stock and the creation of any
other class of preferred stock senior to or pari passu with the Preferred Stock.
The Preferred Stock shall be entitled to dividends only to the extent cash
dividends are declared and paid on the Common Stock on an as if converted basis.
From and after January 1, 1999, the Company shall have an optional right to
redeem all of the outstanding Preferred Stock at a redemption price of $10.75
per share, provided that the average sale price of Common Stock for 60 trading
days prior to the notice of redemption is not less than $21.50 per share. In
February 1998, 930,233 shares of Preferred Stock were converted into an equal
number of shares of Common Stock.
13. SHAREHOLDER RIGHTS PLAN
In connection with the First Data Merger, the Board of Directors adopted a
shareholder rights plan for the Company. The purpose of the shareholder rights
plan is to protect the interests of the Company's shareholders if the Company is
confronted with coercive or potentially unfair takeover tactics by encouraging
third parties interested in acquiring the Company to negotiate with the Board of
Directors.
F-20
54
ENVOY Corporation
Notes to Consolidated Financial Statements
The shareholder rights plan is a plan by which the Company has distributed
rights ("Rights") to purchase (at the rate of one Right per share of Common
Stock) one-tenth of one share of Series A Preferred Stock at an exercise price
of $60 per tenth of a share. The Rights are attached to the Common Stock and may
be exercised only if a person or group (excluding certain share acquisitions as
described in the plan) acquires 20% of the outstanding Common Stock or initiates
a tender or exchange offer that would result in such person or group acquiring
10% or more of the outstanding Common Stock. Upon such an event, the Rights
"flip-in" and each holder of a Right will thereafter have the right to receive,
upon exercise, preferred stock having a value equal to two times the exercise
price. All Rights beneficially owned by the acquiring person or group triggering
the "flip-in" will be null and void. Additionally, if a third party were to take
certain action to acquire the Company, such as a merger or other business
combination, the Rights would "flip-over" and entitle the holder to acquire
shares of the acquiring person with a value of two times the exercise price. The
Rights are redeemable by the Company at any time before they become exercisable
for $0.01 per Right and expire in 2005.
14. COMMON STOCK OFFERING
In August 1996, the Company completed an underwritten public offering of
3,320,000 shares of Common Stock at $26.50 per share. Net proceeds from this
offering were approximately $83,000,000, and were used to retire indebtedness of
$25,000,000 outstanding under a term loan agreement and indebtedness of
approximately $12,900,000 outstanding under a $25,000,000 revolving credit
facility. The remaining proceeds were used for general corporate purposes,
including funding working capital requirements and acquisitions.
15. INCOME TAXES
The provision (benefit) for income taxes was comprised of the following (in
thousands):
DECEMBER 31,
1997 1996 1995
---------------------------------------
Current:
Federal $ 4,545 $ 0 $331
State 2,356 1,053 49
------------------------------------
Total current 6,901 1,053 380
Deferred:
Federal (9,974) 1,294 86
State (2,492) (770) 10
------------------------------------
Total deferred (12,466) 524 96
------------------------------------
Provision (benefit) for income taxes $(5,565) $1,577 $476
====================================
F-21
55
ENVOY Corporation
Notes to Consolidated Financial Statements
The reconciliation of income tax computed by applying the U.S. federal statutory
rate to the actual income tax provision (benefit) follows (in thousands):
DECEMBER 31,
1997 1996 1995
---------------------------------------
Income tax benefit at U.S. federal
statutory rate $(10,247) $(12,690) $(1,335)
Nondeductible merger costs 0 10,459 679
Nondeductible goodwill amortization 4,499 3,411 0
State income taxes, net of federal
benefit (88) 187 39
Change in valuation allowance 238 163 1,130
Other, net 33 47 (37)
----------------------------------------
Income tax provision (benefit) $ (5,565) $ 1,577 $ 476
========================================
The classification of the provision (benefit) for income taxes in the
consolidated statements of operations is as follows (in thousands):
DECEMBER 31,
1997 1996 1995
---------------------------------------
Income tax provision attributable to
continuing operations $(5,565) $1,577 $ 0
Discontinued operations:
Income from operations 0 0 42
First Data transaction expense 0 0 434
--------------------------------------
Total provision from discontinued
operations 0 0 476
--------------------------------------
Total income tax provision $(5,565) $1,577 $476
======================================
F-22
56
ENVOY Corporation
Notes to Consolidated Financial Statements
Deferred income taxes reflects the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. The tax effects of
significant items comprising the Company's temporary differences are as follows
(in thousands):
DECEMBER 31,
1997 1996
-----------------------
Deferred tax liability:
Difference between book and tax depreciation
and amortization related to property and equipment $(2,302) $(2,188)
Difference between book and tax amortization
related to goodwill and other intangibles (3,545) (6,158)
------------------------
Total deferred tax liabilities (5,847) (8,346)
------------------------
Deferred tax assets:
Difference between book and tax amortization related to
write-off of acquired in-process technology 14,018 0
Difference between book and tax treatment
of leased assets 585 516
Reserves and accruals not currently deductible 1,443 1,012
Net operating loss 398 4,629
Difference between book and tax treatment
of investments 900 880
Difference between book and tax treatment
of compensation expense 346 529
Tax credits 583 503
Other 118 117
-----------------------
Total deferred tax assets 18,391 8,186
Valuation allowance for deferred tax assets (1,025) (787)
------------------------
Net deferred tax assets 17,366 7,399
------------------------
Net deferred tax assets (liability) $11,519 $ (947)
=========================
At December 31, 1997, the Company had federal and state net operating loss
carryforwards of approximately $12,400,000 and $17,800,000, respectively. All of
the federal and approximately $7,400,000 of the state net operating losses
relate to the exercise of employee stock options and the tax benefit will be
allocated to equity when realized on the Company's tax returns. These losses
begin to expire in 2003.
Of the $12,400,000 federal net operating losses, $10,800,000 are attributable to
pre-acquisition years of NEIC and their use is limited by the Internal Revenue
Code to approximately $4,700,000 per year. The remaining $1,600,000 of federal
net operating
F-23
57
ENVOY Corporation
Notes to Consolidated Financial Statements
losses are attributable to pre-acquisition years of EMC Express and their use is
limited by the Internal Revenue Code to approximately $141,000 per year.
The valuation allowance at December 31, 1996 relates to the loss on the
investment in EMC Express. The valuation allowance at December 31, 1997 relates
to the loss on the investment in EMC Express plus certain tax credits that
expire in 1997 and might not be realized on the Company's 1997 tax returns. The
allowance was increased in 1997 to include these credits.
16. PROFIT-SHARING PLAN
The Company sponsors 401(k) profit-sharing plans covering all employees who have
completed at least six months of service and are at least 20 and one-half years
of age. Eligible employees may elect to reduce their current compensation and
contribute to the 401(k) plan through salary deferral contributions. The Company
matches employee contributions, up to 25% of the first 6% of compensation
deferred by the employee. The amount of expense for the Company contribution was
approximately $279,000, $314,000 and $20,000 for the years ended December 31,
1997, 1996 and 1995, respectively.
17. FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying amounts reported in the consolidated balance sheet for cash and
cash equivalents, accounts receivable, and accounts payable approximate fair
value. The carrying amount reported in the balance sheet for long-term debt also
approximates fair value. The fair value of the Company's long-term debt is
estimated using discounted cash flows and the Company's current incremental
borrowing rate for similar types of borrowing arrangements.
18. QUARTERLY FINANCIAL DATA (UNAUDITED)
1997
---------------------------------------------------------
1ST QUARTER 2ND QUARTER 3RD QUARTER 4TH QUARTER
---------------------------------------------------------
(In thousands, except per share data)
Revenues $ 26,092 $ 26,416 $ 28,590 $32,595
Gross profit 13,226 13,484 14,779 17,181
Net loss (2,233)(a) (165) (21,210)(b) (155)
Net loss per common share (0.14)(a) (0.01) (1.28)(b) (0.01)
F-24
58
ENVOY Corporation
Notes to Consolidated Financial Statements
1996
-------------------------------------------------------
1ST QUARTER 2ND QUARTER 3RD QUARTER 4TH QUARTER
--------------------------------------------------------
(In thousands, except per share data)
Revenues $ 10,330 $19,590 $21,502 $25,162
Gross profit 5,027 9,842 10,729 12,734
Net loss (33,910)(c) (1,417) (1,963)(d) (1,610)
Net loss per common share (2.97)(c) (0.12) (0.14)(d) (0.11)
(a) The Company recorded a $3,000,000 (or $0.19 per share) write-off of
acquired in-process technology related to the DSS acquisition (see
Note 4).
(b) The Company recorded a $35,000,000 (or $2.12 per share) write-off of
acquired in-process technology related to the HDIC acquisition, less a
related deferred income tax benefit of $13,300,000 (or $0.81 per share)
(see Note 4).
(c) The Company recorded a $30,700,000 (or $2.69 per share) write-off of
acquired in-process technology related to the NEIC and Teleclaims
acquisitions (see Note 4).
(d) The Company recorded a $300,000 (or $0.02 per share) charge related to the
settlement of the EMC lawsuit (see Note 7).
19. SUBSEQUENT EVENTS
On February 27, 1998, the Company completed business combinations with the three
companies operating the ExpressBill patient statement processing and printing
services businesses, for an aggregate of 3,500,000 shares of ENVOY Common Stock.
Shareholders of XpiData, Inc. ("XpiData"), based in Scottsdale, Arizona,
received 1,365,000 shares and shareholders of Professional Office Services, Inc.
("POS") and its affiliated company, Automated Revenue Management, Inc. (together
with XpiData and POS, sometimes collectively referred to as the "ExpressBill
Companies"), both of which are based in Toledo, Ohio, received an aggregate of
2,135,000 shares. The ExpressBill patient statement services include electronic
data transmission and formatting, statement printing and mailing services for
health care providers and practice management system vendors. It is anticipated
that these transactions will be accounted for as poolings of interest.
Accordingly, the Company's historical consolidated financial statements
presented in future reports will be restated to include the accounts and results
of operations of the ExpressBill Companies.
The following unaudited pro forma data summarizes the combined results of
operations of the Company and the ExpressBill Companies as if the combination
had been consummated on December 31, 1997 (in thousands, except per share data):
F-25
59
ENVOY Corporation
Notes to Consolidated Financial Statements
YEARS ENDED DECEMBER 31,
1997 1996 1995
--------- -------- -------
Revenues $ 137,605 $ 90,572 $34,197
Net loss from continuing operations (21,672) (38,443) (2,121)
Net loss from continuing operations, per
common share (1.10) (2.33) (0.14)
Adjustments to the historical financial statements include $980,000, $147,000
and $0 in 1997, 1996 and 1995, respectively, to record income tax provisions for
those entities comprising the ExpressBill Companies that were organized as
S Corporations.
F-26
60
Schedule II
Valuation and Qualifying Accounts
December 31, 1995
Balance at Charged to Balance
Beginning Charged to Other Accounts- Deductions End of
Description of Period Costs & Expenses Describe Describe Period
- --------------------------------------------------------------------------------------------------------------------------------
Allowance for Doubtful Accounts $ 425,000 577,000 a 464,231 $ 537,769
------------------------------------------------------------------------------------------
$ 425,000 577,000 0 464,231 $ 537,769
==========================================================================================
December 31, 1996
Balance at Charged to Balance
Beginning Charged to Other Accounts- Deductions End of
Description of Period Costs & Expenses Describe Describe Period
- --------------------------------------------------------------------------------------------------------------------------------
Allowance for Doubtful Accounts $ 537,769 1,017,000 c 499,014 b 84,719 $ 1,969,064
------------------------------------------------------------------------------------------
$ 537,769 1,017,000 499,014 84,719 $ 1,969,064
==========================================================================================
December 31, 1997
Balance at Charged to Balance
Beginning Charged to Other Accounts- Deductions End of
Description of Period Costs & Expenses Describe Describe Period
- --------------------------------------------------------------------------------------------------------------------------------
Allowance for Doubtful Accounts $ 1,969,064 1,447,500 c 600,000 b 705,036 $ 3,311,528
------------------------------------------------------------------------------------------
$ 1,969,064 1,447,500 600,000 705,036 $ 3,311,528
==========================================================================================
a Of this amount, $264,231 represents allowance for doubtful accounts
associated with the spin-off of the Financial Business which was
transferred to First Data Corporation. The remaining $200,000 represents a
write-off of known uncollectible receivables against the allowance
account.
b This amount represents a write-off of known uncollectible receivables
against the allowance account.
c These amounts represent amounts recorded in connection with the opening
balances of the Acquired Businesses. See Notes 4 and 7 of Notes to
Consolidated Financial Statements.
S-1
61
INDEX TO EXHIBITS
Exhibit No. Description
- ----------- -----------------------------------------------------------------
2.1 Agreement and Plan of Distribution dated September 2, 1994, as
amended through December 16, 1994 (1)
2.2 Agreement and Plan of Merger dated November 30, 1995 by and among
ENVOY, Envoy Acquisition Corporation and NEIC (2)
2.3 Stock Purchase Agreement dated June 14, 1997 by and between ENVOY
Corporation and Advent Investments, Inc. (8)
2.4 Agreement and Plan of Merger dated as of February 23, 1998, by and
among ENVOY Corporation, Envoy Acquisition Corporation,
Professional Office Services, Inc. and Richard B. McIntyre (9)
2.5 Agreement and Plan of Merger dated as of February 23, 1998, by and
among ENVOY Corporation, Envoy Acquisition Corporation, XpiData,
Inc., Michael Marolf, Sr., Michael Marolf, Jr., Jeffrey Marolf and
Lisa Marolf (9)
2.6 Agreement and Plan of Merger dated as of February 23, 1998, by and
among ENVOY Corporation, Envoy Acquisition Subsidiary, Inc.,
Automated Revenue Management, Inc., Patrick J. McIntyre, Terrence
J. McIntyre and Michael S. McIntyre (9)
3.1 Charter, as amended (filed herewith is a Certificate of
Designations setting forth terms of Series B Convertible Preferred
Stock) (Charter as originally amended incorporated by reference to
the Registrant's Annual Report on Form 10-K for the year ended
December 31, 1995)
3.2 By-Laws (1)
4.1 Article IV of ENVOY's Charter, as amended (included in Exhibit
3.1)
4.2 Shareholder Rights Plan (1)
4.3 Registration Rights Agreement dated March 6, 1996 by and among
ENVOY, General Atlantic Partners 25, L.P., GAP Coinvestment
Partners, L.P. and First Union Capital Partners, Inc. (3)
62
Exhibit No. Description
- ----------- --------------------------------------------------------------
4.4 Registration Rights Agreement dated March 6, 1996 by and among
ENVOY and the Purchasers set forth on the signature pages
thereto (3)
4.5 Registration Rights Agreement dated February 27, 1998, by and
between ENVOY and the Persons set forth on the signature pages
thereto.
10.1 Amended and Restated Credit Agreement dated November 8, 1996 among
First Union National Bank of North Carolina, as agent, various
Lenders and ENVOY (4)
MANAGEMENT CONTRACT OR COMPENSATORY PLAN
10.2 Employment Agreement between ENVOY and Fred C. Goad, Jr. (1)
10.3 Employment Agreement between ENVOY and Jim D. Kever (1)
10.4 Employment Agreement between ENVOY and Kevin M. McNamara (5)
10.5 Employment Agreement between ENVOY and Harlan F. Seymour
10.6 Amended and Restated 1995 Employee Stock Incentive Plan (6)
10.7 Amended and Restated 1995 Stock Option Plan for Outside
Directors (6)
10.8 ENVOY Corporation Employee Stock Purchase Plan (7)
10.9 1998 ExpressBill Stock Option Plan
10.10 1992 Incentive Plan (1)
10.11 1992 Non-Employee Directors Stock Option Plan (1)
10.12 1990 Officer and Employee Stock Option Plan (1)
10.13 1990 Director Stock Option Plan (1)
10.14 1987 Stock Option Plan (1)
10.15 Form of Indemnification Agreement (1)
63
Exhibit No. Description
- ----------- --------------------------------------------------------------
21 Subsidiaries
23 Consent of Independent Auditors
27 Financial Data Schedule
- ------------
(1) Incorporated by reference to the Registrant's Form 10, as amended
No. 0-25062.
(2) Incorporated by reference to the Registrant's Current Report on Form 8-K
filed December 7, 1995.
(3) Incorporated by reference to the Registrant's Current Report on Form 8-K
filed March 21, 1996.
(4) Incorporated by reference to the Registrant's Quarterly Report on Form
10-Q for the quarter ended September 30, 1996.
(5) Incorporated by reference to the Registrant's Registration Statement on
Form S-3, as amended, No. 333-04433.
(6) Incorporated by reference to the Registrant's Annual Report on Form 10-K
for the year ended December 31, 1996.
(7) Incorporated by reference to the Registrant's Proxy Statement, dated April
30, 1997 for the Annual Meeting of Shareholders held June 19, 1997.
(8) Incorporated by reference to the Registrant's Current Report on Form 8-K
filed June 23, 1997.
(9) Incorporated by reference to the Registrant's Current Report on Form 8-K
filed February 25, 1998.